# EDGAR Filing Document

**Accession Number:** 0001939965
**File Stem:** 0001213900-25-112727
**Filing Date:** 2025-11
**Character Count:** 191146
**Document Hash:** 5130f1a6b171bb73fa9b3ccad03a5f59
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-112727.hdr.sgml**: 20251119

**ACCESSION NUMBER**: 0001213900-25-112727

**CONFORMED SUBMISSION TYPE**: F-3ASR

**PUBLIC DOCUMENT COUNT**: 25

**FILED AS OF DATE**: 20251119

**DATE AS OF CHANGE**: 20251119

**EFFECTIVENESS DATE**: 20251119

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Brera Holdings PLC
- **CENTRAL INDEX KEY:** 0001939965
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-AMUSEMENT & RECREATION SERVICES [7900]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 000000000
- **STATE OF INCORPORATION:** L2
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** F-3ASR
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-291657
- **FILM NUMBER:** 251500257

**BUSINESS ADDRESS:**
- **STREET 1:** CONNAUGHT HOUSE, 5TH FLOOR
- **STREET 2:** ONE BURLINGTON ROAD
- **CITY:** DUBLIN 4
- **STATE:** L2
- **ZIP:** D04 C5Y6
- **BUSINESS PHONE:** 949-233-7869

**MAIL ADDRESS:**
- **STREET 1:** CONNAUGHT HOUSE, 5TH FLOOR
- **STREET 2:** ONE BURLINGTON ROAD
- **CITY:** DUBLIN 4
- **STATE:** L2
- **ZIP:** D04 C5Y6

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Brera Holdings Ltd
- **DATE OF NAME CHANGE:** 20220726

**As filed with the Securities and Exchange Commission on November 19, 2025**

**Registration No. 333-** 

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**FORM F-3**

**REGISTRATION STATEMENT UNDER**

**THE SECURITIES ACT OF 1933**

**BRERA HOLDINGS PLC**

(Exact name of registrant as specified in its charter)

**Not Applicable**

(Translation of registrant's name into English)

---

| | |
|:---|:---|
| **Ireland** | **Not Applicable** |
| (State or other jurisdiction of <br> incorporation or organization) | (I.R.S. Employer <br> Identification Number) |

---

**Connaught House, 5th Floor**

**One Burlington Road**

**Dublin 4**

**D04 C5Y6**

**Ireland**

**+353 1 237 3700**

(Address and telephone number of registrant's principal executive offices)

**Cogency Global Inc.**<br> **122 East 42nd Street, 18th Floor**<br> **New York, NY 10168**<br> **(800) 221-0102**<br> (Name, address, and telephone number of agent for service)<br>

---

| |
|:---|
| *Copies to:* |
| **Ross D. Carmel, Esq.**<br> **Jeffrey Wofford, Esq.**<br> **Sichenzia Ross Ference Carmel LLP**<br> **1185 Avenue of the Americas, 31st Floor**<br> **New York, NY 10036**<br> **Phone: (212) 930-9700** |

---

**Ethan Silver, Esq.**

**Daniel Forman, Esq.**

**Lowenstein Sandler LLP**

**1251 Avenue of the Americas**

**New York, New York 10022**

**Phone: (212) 262-6700**

**Approximate date of commencement of proposed sale to the public:** From time to time after this Registration Statement becomes effective.

If only securities being registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box. ☐

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

If this Form is a registration statement pursuant to General Instruction I.C. or a post-effective amendment thereto that shall become effective upon filing with the Commission pursuant to Rule 462(e) under the Securities Act, check the following box. ☒

If this Form is a post-effective amendment to a registration statement filed pursuant to General Instruction I.C. filed to register additional securities or additional classes of securities pursuant to Rule 413(b) under the Securities Act, check the following box. ☐

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

Emerging growth company ☒

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

&nbsp;&nbsp;&nbsp;&nbsp;† The term
 "new or revised financial accounting standard" refers to any update issued by the Financial Accounting Standards Board
 to its Accounting Standards Codification after April 5, 2012.

***PROSPECTUS***

![](image_001.jpg)

 ****

**BRERA HOLDINGS PLC**

**79,748,354 Class B Ordinary Shares**

**PIPE Pre-Funded Warrants to Purchase up to 5,161,152 Class B Ordinary Shares**

**5,161,152 Class B Ordinary Shares Underlying the PIPE Pre-Funded Warrants**

**PIPE Common Warrants to Purchase up to 66,666,668 Class B Ordinary Shares**

**66,666,668 Class B Ordinary Shares Underlying PIPE Common Warrants**

**Strategic Advisor Pre-Funded Warrants to Purchase up to 3,333,330 Class B Ordinary Shares**

**3,333,330 Class B Ordinary Shares Underlying Strategic Advisor Pre-Funded Warrants**

**Strategic Advisor Common Warrants 1 to Purchase up to 1,666,667 Class B Ordinary Shares**

**1,666,667 Class B Ordinary Shares Underlying Strategic Advisor Common Warrants 1**

**10,745 Class B Ordinary Shares Underlying Warrants**

**16,000 Class B Ordinary Shares Underlying Series A Preferred Stock**

This prospectus relates to the offer and resale by the selling securityholders identified herein, or their permitted transferees (the "Selling Securityholders"), of (A) up to 156,602,916 of our Class B Ordinary Shares, nominal value, $0.05 per share ("Class B Ordinary Shares") consisting of: (i) 61,505,516 Class B Ordinary Shares issued to the investors in the PIPE Offering (as defined herein)(the "PIPE Shares"); (ii) 10,372,130 Class B Ordinary Shares issued to the Strategic Advisors (as defined herein) upon the partial exercise of the Strategic Advisor Pre-Funded Warrants (as defined herein), the partial exercise of the Strategic Advisor Common Warrants 1 (as defined herein), the exercise in full of the Strategic Advisor Common Warrants 2 (as defined herein) and the exercise in full of the WPA Investor Warrants (as defined herein) (the "Strategic Advisor Shares"); (iii) 1,000,334 Class B Ordinary Shares issued to Daniel J. McClory or entities owned and controlled by Daniel J. McClory (the "McClory Shares"); (iv) 5,858,695 Class B Ordinary Shares issued to Boustead & Company Limited upon the exercise in full of three Class B Ordinary Share purchase warrants (the "BCL Shares"); (v) 93,887 Class B Ordinary Shares issued to Boustead Securities, LLC upon the exercise in full of several warrants (the "BSL Shares"); (vi) 131,821 Class B Ordinary Shares issued to investors upon conversion of Class B Preferred Stock (the "Series B Conversion Shares"); (vii) 785,971 shares issued to certain legacy shareholders of the Company (the "Legacy Shares"); (viii) up to 5,161,152 Class B Ordinary Shares issuable upon the exercise of the PIPE Pre-Funded Warrants (as defined herein), which have an exercise price of $0.05 per share (the "PIPE Pre-Funded Warrant Shares"); (ix) up to 66,666,668 Class B Ordinary Shares issuable upon exercise of the PIPE Common Warrants (as defined herein), which have an exercise price of $6.75 per share (the "PIPE Warrant Shares"); (x) up to 3,333,330 Class B Ordinary Shares issuable to the Strategic Advisors upon exercise of certain of the Strategic Advisor Pre-Funded Warrants (as defined herein) which have an exercise price of $0.05 per share (the "Strategic Advisor Pre-Funded Warrant Shares"); (xi) up to 1,666,667 Class B Ordinary Shares issuable upon exercise of the Strategic Advisor Common Warrants 1 (as defined herein) which have an exercise price of $6.75 per share (the "Strategic Advisor Warrant 1 Shares" and together with the Strategic Advisor Pre-Funded Warrant Shares, the Strategic Advisor Warrant Shares"); (xii) 16,000 Class B Ordinary Shares issuable upon conversion of Series A Preferred Stock (the "Series A Conversion Shares"); and (xiii)10,745 Class B Ordinary Shares issuable upon warrants issued to certain legacy shareholders of the Company, which have an exercise price of $13.50 per share (the "Legacy Warrant Shares") and (B) warrants to purchase 76,827,817 Class B Ordinary Shares, consisting of (i) the PIPE Pre-Funded Warrants to purchase up to 5,161,152 Class B Ordinary Shares; (ii) the PIPE Common Warrants to purchase up to 66,666,668 Class B Ordinary Shares, (iii) the Strategic Advisor Pre-Funded Warrants to purchase up to 3,333,330 Class B Ordinary Shares and (iv) the Strategic Advisor Common Warrants 1 to purchase up to 1,666,667 Class B Ordinary Shares.

We refer to the (i) PIPE Shares, (ii) the PIPE Pre-Funded Warrants, (iii) the PIPE Common Warrants, (iv) PIPE Pre-Funded Warrant Shares; (v) PIPE Warrant Shares, (vi) Strategic Advisor Shares, (vii) Strategic Advisor Pre-Funded Warrants, (viii) Strategic Advisor Common Warrants 1; (ix) Strategic Advisor Warrant Shares; (x) Legacy Shares, (xi) McClory Shares, (xii) BCL Shares, (xiii) BSL Shares; (xiv) Series A Conversion Shares, (xv) Series B Conversion Shares and (xvi) Legacy Warrant Shares, collectively as the "Securities" in this prospectus.

We are registering the issuance and/or resale of the Securities to satisfy certain registration obligations we have and certain registration rights we have granted. The Selling Securityholders may from time to time sell, transfer or otherwise dispose of any or all of the Securities in a number of different ways and at varying prices. See the "Plan of Distribution" section of this prospectus for more information.

We are not selling any Securities in this offering, and we will not receive any proceeds from the sale of the Securities by the Selling Securityholders. We will, however, receive up to approximately $461,674,735 in proceeds if the PIPE Pre-Funded Warrants, PIPE Common Warrants, the Strategic Advisor Pre-Funded Warrants, the Strategic Advisor Common Warrants 1 and the warrants related to the Legacy Warrant Shares are exercised in full (assuming no cashless exercises and excluding fees payable to the placement agent in the PIPE Offering).

The Class B Ordinary Shares are listed on The Nasdaq Capital Market tier of The Nasdaq Stock Market LLC ("Nasdaq") under the symbol "SLMT". On November 18, 2025, the closing sale price of the Class B Ordinary Shares on Nasdaq was $6.67.

The Selling Securityholders may offer all or part of the Securities for resale from time to time through public or private transactions, at either prevailing market prices or at privately negotiated prices. The Selling Securityholders will bear all commissions and discounts, if any, attributable to the sales of Securities. We will bear all other costs, expenses and fees in connection with the registration of the Securities. See "Plan of Distribution" beginning on page 18 for more information about how the Selling Securityholders may sell or dispose of their Securities.

This prospectus provides a general description of the securities being offered. You should read this prospectus and the registration statement of which it forms a part before you invest in any securities.

**Investing in our Class B Ordinary Shares involves a high degree of risk and uncertainty. See "Risk Factors" beginning on page 9 of this prospectus and the other documents that are incorporated by reference in this prospectus.**

**NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.**

The date of this prospectus is November 19, 2025.

**TABLE OF CONTENTS**

---

| | |
|:---|:---|
| [About This Prospectus](#a_001) | ii |
| [Cautionary Note Regarding Forward-Looking Statements](#a_002) | iii |
| [Prospectus Summary](#a_003) | 1 |
| [The Offering](#a_004) | 8 |
| [Risk Factors](#a_005) | 9 |
| [Use of Proceeds](#a_006) | 10 |
| [Dividend Policy](#a_007) | 10 |
| [Description of Share Capital](#a_008) | 10 |
| [Selling Securityholders](#a_009) | 12 |
| [Plan of Distribution](#a_010) | 18 |
| [Legal Matters](#a_011) | 21 |
| [Experts](#a_012) | 21 |
| [Where You Can Find More Information](#a_013) | 21 |
| [Incorporation of Certain Information by Reference](#a_014) | 22 |

---

i

**ABOUT THIS PROSPECTUS**

This prospectus is part of an automatic shelf registration statement that we have filed with the U.S. Securities and Exchange Commission (the "SEC") as a "well-known seasoned issuer" as defined in Rule 405 under the Securities Act of 1933, as amended (the "Securities Act"). Under this registration statement, the Selling Securityholders may sell from time to time in one or more offerings the Securities described in this prospectus. You should read this prospectus, and any applicable prospectus supplement, together with the information incorporated herein by reference as described under the headings "*Where You Can Find More Information*" and "*Incorporation of Certain Information by Reference*."

You should rely only on the information that we have provided or incorporated by reference in this prospectus, which may be amended, supplemented, or superseded from time to time by other reports that we subsequently file with the SEC. We have not authorized, nor has any Selling Securityholder authorized, any dealer, salesman, or other person to give any information or to make any representation other than those contained or incorporated by reference in this prospectus. You should not rely upon any information or representation not contained or incorporated by reference in this prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you.

This prospectus does not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does this prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. You should not assume that the information contained in this prospectus is accurate on any date subsequent to the date set forth on the front of the document or that any information we have incorporated by reference is correct on any date subsequent to the date of the document incorporated by reference, even though this prospectus is delivered or securities are sold on a later date.

For the avoidance of doubt, any offer of securities (within the meaning of the Prospectus Regulation (EU) 2017/1129 (the "Prospectus Regulation")) contained in this prospectus is addressed to less than 150 natural or legal persons per member state of the European Union and accordingly, there is no legal obligation or requirement to publish this prospectus in the European Union in accordance with the provisions of the Prospectus Regulation.

In this prospectus unless the context indicates otherwise, "we," "us," "our," "Brera Holdings," "the Company," "our company" and similar references refer to the operations of Brera Holdings PLC, a public limited company incorporated in the Republic of Ireland, and its consolidated subsidiaries.

ii

**CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS**

This prospectus including the documents that we incorporate by reference herein, contains, and may contain, forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), including statements regarding our future financial condition, business strategy and plans and objectives of management for future operations. Forward-looking statements include all statements that are not historical facts. In some cases, you can identify forward-looking statements by terminology such as "believe," "will," "may," "estimate," "continue," "anticipate," "intend," "should," "plan," "might," "approximately," "expect," "predict," "could," "potentially" or the negative of these terms or other similar expressions.

Forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that could cause our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and subject to such risks, uncertainties and other factors. Discussions containing forward-looking statements may be found, among other places, in the section entitled "*Risk Factors*" in this prospectus, and the sections entitled "*Business*," "*Risk Factors*" and "*Management's Discussion and Analysis of Financial Condition and Results of Operations*" contained in the documents incorporated by reference herein, including our most recent Annual Report on Form 20-F and our Reports on Form 6-K, as well as any amendments thereto.

The forward-looking statements contained in this prospectus represent our judgment as of the date of this prospectus. We caution readers not to place undue reliance on such statements. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, even if new information becomes available or other events occur in the future. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements contained below and throughout this prospectus. All forward-looking statements contained in this prospectus or any document incorporated by reference herein or therein are qualified in their entirety by this cautionary statement.

Forward-looking statements appear in a number of places throughout this prospectus and include statements regarding our intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things:

● our goals and strategies;

● our future business development, financial condition and results of operations;

● our projected revenues, profits, earnings and other estimated financial information;

● our ability to secure additional funding necessary for the expansion of our business;

● the growth of and competition trends in our industry;

● our expectations regarding the popularity and competitive success of our sports teams;

● our ability to maintain strong relationships with our fans, supporters and sponsors;

● our expectation regarding the use of proceeds from any exercise of warrants;

● the accuracy and completeness of the data underlying our third-party sources' industry and market analyses and projections;

● our ability to comply with continued listing requirements of Nasdaq;

● fluctuations in general economic and business conditions in the markets in which we operate;

● relevant government policies and regulations relating to our industry;

● the success of our new SOL Treasury Policy (as defined below);

● the volatile and unpredictable changes in the price of SOL (as defined below);

● the expected growth of the SOL ecosystem;

● the availability of opportunities to stake SOL; and

● new or additional governmental regulation.

You should not rely upon forward-looking statements as predictions of future events. We cannot assure you that the events and circumstances reflected in the forward-looking statements will be achieved or occur.

iii

**PROSPECTUS SUMMARY**

 

*This summary highlights selected information contained elsewhere in or incorporated by reference into this prospectus and in the documents we incorporate by reference. This summary is not complete and does not contain all of the information that you should consider before deciding whether to invest in our securities. You should read this entire prospectus carefully, including the risks associated with an investment in our company discussed in the "Risk Factors" section of this prospectus and in the documents we incorporate by reference, before making an investment decision. Some of the statements in this prospectus and the other documents incorporated by reference are forward-looking statements. See the section titled "Cautionary Note Regarding Forward-Looking Statements."*

**Company Overview**

Brera Holdings is an Irish holding company focused on multi-club ownership ("MCO") and expanding its global portfolio of men's and women's sports clubs with increased opportunities to earn tournament prizes, gain sponsorships, obtain transfer fees and provide other professional football- and sports-related consulting services.

Brera FC is the first football club that we acquired in July 2022. Brera FC, known as "The Third Team of Milan," is an amateur football association which has been building an alternative football legacy since its founding in 2000. In March 2023, we expanded to Africa with the establishment of Brera Tchumene FC, a team admitted to the Second Division League in Mozambique, a country of nearly 32 million people. Brera Tchumene FC was promoted to Mocambola (First Division for Mozambique), for the 2024 season. In February 2025 we decided to pause operations of Brera Tchumene FC due to the geopolitical situation in the country, deciding instead to further invest in the Mozambican football team Black Bulls, the current champion of the Mocambola league. In April 2023, we acquired 90% of the European first division football team Fudbalski Klub Akademija Pandev in North Macedonia, a country with participation rights in two major Union of European Football Association ("UEFA") competitions, the Europa League and the Europa Conference League, and rebranded the team Brera Strumica FC. In June 2023, we acquired, through open market purchases, a strategic stake in Manchester United PLC, which is listed on the New York Stock Exchange, and a portion of our stake was subject to a tender offer by Sir Jim Radcliffe and sold at a 74% realized gain in February 2024.

On June 17, 2025, we sold our 48.94% interest in Italian Serie A1 women's professional volleyball team, UYBA Volley S.s.d.a.r.l and no longer have volleyball teams in our portfolio. In September 2023, we assumed control of Bayanzurkh Sporting Ilch FC, a team in the Mongolian National Premier League, which became Brera Ilch FC when the football season resumed in March 2024. In February 2024, we established the Brera Holdings Advisory Board, whose current members are Major League Soccer founder and World Cup director Alan Rothenberg, luxury lifestyle executive Massimo Ferragamo, sports business leaders Paul Tosetti and Marshall Geller, Italian football icon Giuseppe Rossi, and economist Arthur Laffer. In July 2024, we established a joint stock company for the North Macedonian women's football club Tiverija Strumica, now known as Brera Tiverija FC, a wholly-owned subsidiary of Brera Strumica FC. From December 2024, until June 2025 we acquired 52% of the Italian Serie B football club Juve Stabia. In October 2025 we decided to cease operations in Mozambique and Mongolia.

**Recent Developments**

***Appointment of Executive Officers***

 ****

On November 4, 2025,we appointed Justin Bowes as our Chief Legal Officer and Board Director Dr. Alberto Libanori as Head of Operations.

***Our Solana Treasury Strategy***

 ****

**<u>Adoption of a Solana Treasury Policy</u>**

We have adopted a treasury policy (the "Treasury Policy") under which the principal holding in our treasury reserve on the balance sheet will be allocated to digital assets, starting with Solana ("SOL"). Our Board of Directors (the "Board") approved our new Treasury Policy on September 21, 2025, authorizing long-term accumulation of SOL.

On September 23, 2025, we entered into a strategic advisor agreement (the "Strategic Advisor Agreement") with Tarek Alnuaimi, Guy Hirsch, Keren Maimon, Ron Sade and Alyazi Almheiri (the "Strategic Advisors") pursuant to which the Strategic Advisors will provide strategic advice and guidance relating to our business, operations, growth initiatives and industry trends in the cryptocurrency technology sector. We also intend to stake our treasury assets with one or more SOL validator service providers.

In addition to operating our sports club business, our management will focus its resources on our Treasury Policy and a significant portion of the balance sheet will be allocated to holding SOL in our digital asset treasury.

Currently our Treasury Policy is primarily dedicated to SOL, and we do not intend to allocate treasury assets to other digital assets in the near term. As a result, our assets are highly concentrated in a single digital asset. Adverse developments specific to SOL, its protocol, or its ecosystem could have a disproportionate impact on our financial condition and results of operations. We hedge our SOL holdings with a mix of call options, put options as well as other derivatives via total return swaps.

Our Treasury Policy is intended to bring value to our stockholders through the following:

● utilizing intelligent capital markets issuances, including the issuance of both equity and convertible debt, where we may issue capital for the benefit of stockholders to purchase and hold more SOL;

● staking the majority of the SOL in our treasury to earn a staking yield and turn the treasury into a productive asset;

● purchasing locked SOL at a discount to the current spot price; and

● selling our SOL holdings, whether on the open market, through block trades, or other negotiated transactions, for various reasons and at various times, including, in order to repurchase our Class B Ordinary Shares when our Board believes such repurchases will result in accretive value creation for our shareholders and at such times when it is legally permissible to do so.

We believe that SOL is the fastest and most used public blockchain in the world, processing more transactions and generating more onchain fee revenue than all other blockchains combined.

There can be no assurance that the value of SOL will increase, and investors should carefully consider the risks associated with digital assets.

**<u>How We Earn Staking Rewards</u>**

To earn staking rewards, we intend to delegate our SOL to third parties who we believe are leading SOL validators via Solana's in-protocol delegation system while keeping the SOL held by third party custodians. This means we intend to deposit our SOL into a stake account, which is then delegated to a validator's vote account. We intend to validators who are integrated into our qualified custodians' platforms, allowing us to stake SOL to validators directly from our custody accounts. Of the validators that will be integrated into our qualified custodians, our team intends to stake to those who, in our opinion, have demonstrated a track record of high performance, high yield generation, and attractive delegator economics. We intend to use multiple validators to seek to maximize the return on our SOL treasury and to mitigate the risk of having only one or two validators for our treasury staking. We will also build our own validators or build in partnership with others and stake to these validators.

**<u>How We Manage Liquidity</u>**

We acknowledge that during the deactivation period, staked SOL is not earning rewards and is not yet liquid. We factor this into our liquidity and risk management framework.

Our intended staking program involves a temporary loss of transferability of staked SOL during the "deactivation" or cooldown period. Under normal conditions, we expect to regain complete control over un-staked SOL within approximately 48 hours; however, network conditions could extend this period. To mitigate liquidity risk, we intend to maintain a portion of our treasury in un-staked SOL and cash to meet short-term obligations. Our use of SOL options may involve margin requirements or collateral posting, which could reduce available liquidity. Option premiums paid or received may also create volatility in our near-term cash flows. A certain portion of our holdings is comprised of SOL that is programmatically locked by the FTX estate. As such the release of such locked SOL is outside our control.

**<u>Use of Custodians and Storage of SOL</u>**

We solely utilize third-party qualified custodians to hold our SOL, other than the portion of our SOL held through a single non-qualified custodian, as set forth below. We do not self-custody our SOL. We use qualified custodians that utilize risk management and operational best practices related to hot vs. cold storage, access controls, custody technology and insurance, among other practices. We are in the process of onboarding with other qualified custodians to ensure that we mitigate our SOL treasury risk through the use of several qualified custodians.

Our primary custodians generally maintain the majority of their custodied SOL holdings in cold storage (>95%), with hot wallets used only for limited operational purposes. Custodians employ SOC 2–audited security controls, geographic redundancy, multi-person approval processes, and conduct key-generation ceremonies in offline, secure facilities. Private keys are never exposed to networked devices. Custodians maintain insurance coverage, which is in addition to policies we maintain ourselves. Our custody agreements typically run for one to three years, may be terminated on 30 days' notice, and include fees for storage and transactions. Our qualified custodians do not rehypothecate or otherwise use our SOL. We may self-custody our SOL in the future.

**<u>Use of DeFi Protocols</u>**

We may from time to time interact with decentralized finance ("DeFi") protocols, either directly or indirectly through staking, validator operations, custody arrangements, or liquidity management activities. DeFi protocols generally rely on open-source smart contracts deployed on public blockchains, including SOL. While these smart contracts are intended to operate automatically according to their code, they may contain coding errors, vulnerabilities, or design flaws that can be exploited.

**<u>SOL - The Token of the Solana Blockchain</u>**

SOL is the native token of the Solana blockchain. SOL was created with an initial supply of 500 million SOL, though much of the initial supply was locked or earmarked for various use cases including the community, the foundation and investors. New SOL is brought into existence primarily through inflationary rewards distributed to validators and delegators. The SOL staking yield is made up of three primary components: inflationary rewards, transaction/priority fees, and maximal extractable value. Inflationary rewards started out at 8.0%, and are currently 4.3%, and will fall 15% every epoch-year until they reach a long-term floor of 1.5%. Unlock schedules applicable to these allocations may periodically increase circulating supply, creating potential selling pressure and adversely affecting the price of SOL. Historically, 50% of all transaction fees were burned (with the other 50% going to the validator), but now all transaction fees go to the validator after the passage and adoption of the Solana Improvement Document 96.

**<u>How SOL is Used</u>**

SOL is used as part of Solana's proof-of-stake consensus mechanism. In general, proof-of-stake blockchains have block producers called validators that run nodes, bond or stake the protocol's native token, propose blocks when chosen to do so, and validate/sign the transactions and blocks of others when not. Validators are chosen to produce a block in proportion to their stake, which makes it extremely costly for bad actors to attempt to control the network and add invalid transactions to the blockchain. Validators receive staking rewards for the work they perform, which further incentivizes validators to behave properly, as they would otherwise miss out on such rewards. Other proof-of-stake networks often "slash" some or all of a validator's stake if it intentionally or unintentionally performs its duties poorly, for example, by double-signing a transaction, though Solana has not implemented slashing at this time. In addition to its use within consensus, SOL is also a "gas token", meaning that users of the Solana blockchain pay SOL to validators (and delegators) as compensation for processing their transactions.

We see three particularly notable items giving Solana a technical advantage compared to many smart contract blockchain peers. Solana's proof-of-history gives validators a notion of time and allows them to produce blocks without requiring the network to first agree upon the current block, resulting in speed advantages. Further, unlike peer blockchains that often use single-threaded virtual machines, Solana enables parallel transaction execution to increase throughput and take advantage of future hardware improvements resulting from increased CPU core counts. In addition, Solana is optimized for speed and security, and is naturally growing into decentralization as hardware and bandwidth costs fall over time, positioning it well along the Blockchain Trilemma.

While Solana Labs and the Solana Foundation have played important roles in the development of the Solana ecosystem, no single entity owns or controls the Solana network. However, concentration of influence in these entities, particularly in early-stage protocol governance, presents risks that investors should consider.

**<u>The Solana Ecosystem</u>**

Solana's performance and technical capabilities enable many use cases from DeFi to decentralized physical infrastructure networks, AI agents, social media, gaming, stablecoins, real-world assets, among others. We believe Solana is advantaged by best-in-class technology and strong network effects that have attracted a large, growing, and vibrant ecosystem of users, developers, and decentralized applications.

**<u>Regulations</u>**

Depending on the regulatory characterization of Solana, the markets for cryptocurrency in general, and our activities in particular, our business and our Solana acquisition strategy may be subject to regulation by one or more regulators in the United States and globally. Ongoing and future regulatory actions may alter, to a materially adverse extent, the nature of digital assets markets, the participation of industry participants, including service providers and financial institutions in these markets, and our ability to pursue our SOL strategy. Additionally, U.S. state and federal and foreign regulators and legislatures have taken action against industry participants, including digital assets businesses, and enacted restrictive regimes in response to adverse publicity arising from hacks, consumer harm, or criminal activity stemming from digital assets activity. U.S. federal and state energy regulatory authorities are also monitoring the total electricity consumption of cryptocurrency mining, and the potential impacts of cryptocurrency mining to the supply and dispatch functionality of the wholesale grid and retail distribution systems. Many state legislative bodies have passed, or are actively considering, legislation to address the impact of cryptocurrency mining in their respective states.

The Commodities Futures Trading Commission (the "CFTC") takes the position that some digital assets fall within the definition of a "commodity" under the Commodities Exchange Act of 1936, as amended (the "CEA"). Under the CEA, the CFTC has broad enforcement authority to police market manipulation and fraud in spot digital assets markets in which we may transact. Beyond instances of fraud or manipulation, the CFTC generally does not oversee cash or spot market exchanges or transactions involving digital asset commodities that do not utilize margin, leverage, or financing. In addition, CFTC regulations and CFTC oversight and enforcement authority apply with respect to futures, swaps, other derivative products and certain retail leveraged commodity transactions involving digital asset commodities, including the markets on which these products trade.

In addition, because transactions in SOL provide a degree of anonymity, they are susceptible to misuse for criminal activities, such as money laundering. This misuse, or the perception of such misuse, could lead to greater regulatory oversight of SOL and SOL platforms, and there is the possibility that law enforcement agencies could close SOL platforms or other SOL-related infrastructure with little or no notice and prevent users from accessing or retrieving SOL held via such platforms or infrastructure.

As noted above, activities involving SOL and other digital assets may fall within the jurisdiction of more than one financial regulator and various courts and such laws and regulations are rapidly evolving and increasing in scope The laws and regulations applicable to SOL and digital assets are evolving and subject to interpretation and change.

Governments around the world have reacted differently to digital assets; certain governments have deemed them illegal, and others have allowed their use and trade without restriction, while in some jurisdictions, such as the U.S., digital assets are subject to overlapping, uncertain and evolving regulatory requirements.

As digital assets have grown in both popularity and market size, the U.S. Executive Branch, Congress and a number of U.S. federal and state agencies, including the Financial Crimes Enforcement Network, the CFTC, the SEC, the Financial Industry Regulatory Authority, the Consumer Financial Protection Bureau, the Department of Justice, the Department of Homeland Security, the Federal Bureau of Investigation, the Internal Revenue Service and state financial regulators, have been examining the operations of digital asset networks, digital asset users and digital asset exchanges, with particular focus on the extent to which digital assets can be used to violate state or federal laws, including to facilitate the laundering of proceeds of illegal activities or the funding of criminal or terrorist enterprises, and the safety and soundness and consumer-protective safeguards of exchanges or other service-providers that hold, transfer, trade or exchange digital assets for users. Many of these state and federal agencies have issued consumer advisories regarding the risks posed by digital assets to investors. In addition, federal and state agencies, and other countries have issued rules or guidance regarding the treatment of digital asset transactions and requirements for businesses engaged in activities related to digital assets.

***September 2025 PIPE Transaction***

**<u>Securities Purchase Agreements</u>**

 **

On September 18, 2025, we entered into securities purchase agreements (the "PIPE Securities Purchase Agreements") with certain accredited investors (the "Purchasers") pursuant to which the Company agreed to sell and issue to the Purchasers in a private placement offering (the "PIPE Offering") an aggregate offering of (i) a combination of 61,505,516 Class B Ordinary Shares, and Class B Ordinary Share purchase warrants (the "PIPE Common Warrants") to purchase 61,505,516 Class B Ordinary Shares, at a combined offering price of $4.50 per Class B Ordinary Share and PIPE Common Warrant to purchase one Class B Ordinary Share and (ii) a combination of pre-funded warrants (the "PIPE Pre-Funded Warrants") to purchase 5,161,152 Class B Ordinary Shares and PIPE Common Warrants to purchase 5,161,152 Class B Ordinary Shares, at a combined offering price of $4.45 per PIPE Pre-Funded Warrant to purchase one Class B Ordinary Share and PIPE Common Warrant to purchase one Class B Ordinary Share.

The PIPE Common Warrants will be immediately exercisable for 36 months after issuance at an exercise price of $6.75 per share. The PIPE Pre-Funded Warrants will be immediately exercisable and may be exercised at any time until all of the PIPE Pre-Funded Warrants issued in the PIPE Offering are exercised in full at an exercise price of $0.05 per share. Each Purchaser's ability to exercise its PIPE Pre-Funded Warrants and PIPE Common Warrants, as applicable, in exchange for Class B Ordinary Shares is subject to certain beneficial ownership limitations set forth therein.

The PIPE Offering closed on September 23, 2025 with aggregate gross proceeds of approximately $300 million, which amount was paid in cash, USD Coin, Tether, or SOL (or a combination thereof).

**<u>Registration Rights Agreement</u>**

 ****

In connection with entering into the PIPE Securities Purchase Agreements, on September 18, 2025, the Company and the Purchasers entered into a Registration Rights Agreement (the "Registration Rights Agreement"), pursuant to which the Company agreed to file a registration statement with the SEC, within 30 days of the closing of the PIPE Offering registering the resale of, among others, the PIPE Shares, the PIPE Pre-Funded Warrants, the PIPE Pre-Funded Warrant Shares, the PIPE Common Warrants, the PIPE Warrant Shares, the Strategic Advisor Shares that were issued upon the exercise of Strategic Advisor Pre-Funded Warrants, the Strategic Advisor Warrants and the Strategic Advisor Warrant Shares.

The registration statement of which this prospectus forms a part is being filed in part to satisfy our obligations under the Registration Rights Agreement.

 ****

***Strategic Advisor Agreement***

On September 18, 2025, the Company entered into a Strategic Advisor Agreement with the Strategic Advisors, pursuant to which the Strategic Advisors will provide the Company with strategic advice and guidance relating to the Company's business, operations and growth initiatives, and industry trends in the cryptocurrency technology sector. In return for their services, the Strategic Advisors will receive (i) cash compensation equal to 1% per annum of the amount of the Company's SOL Assets Under Management ("SOL AUM") (as determined in accordance with the provisions of the Strategic Advisor Agreement); (ii) prefunded warrants (the "Strategic Advisor Pre-Funded Warrants") to purchase a number of Class B Ordinary Shares equal to 10% of the aggregate number of Class B Ordinary Shares and pre-funded warrants issued pursuant to the Securities Purchase Agreements (the "Strategic Advisor Pre-Funded Warrant Shares"); (iii) warrants (the "Strategic Advisor Common Warrants 1") to purchase an amount of Class B Ordinary Shares equal to, in the aggregate, 50.0% of the aggregate number of Strategic Advisor Pre-Funded Warrant Shares; and (iv) warrants (the "Strategic Advisor Common Warrants 2", and together with the Strategic Advisor Pre-Funded Warrants and the Strategic Advisor Common Warrants 1, the "Strategic Advisor Warrants") to purchase, in the aggregate, an amount of Class B Ordinary Shares equal to 9.0% of the aggregate number of Class B Ordinary Shares and pre-funded warrants issued pursuant to the Securities Purchase Agreements. The Strategic Advisor Agreement was amended on October 31, 2025 to correct the exercises prices of the Strategic Advisor Common Warrants 2. All of the Strategic Advisor Common Warrants 2 were exercised on a cashless basis.

***Concurrent Securities Issuances***

On September 23, 2025, the Company entered into a Registration Rights Agreement (the "DM Registration Rights Agreement 1") with certain entities owned and controlled by Daniel J. McClory (the "DM Entities"), an executive director of the Company, pursuant to which the Company agreed to file a registration statement with the SEC, within 30 days of the closing of the PIPE Offering registering the resale of the Class B Ordinary Shares held by the DM Entities. The Pinehurst Conversion Shares and the McClory Shares have been included in the registration statement related to this prospectus pursuant to the DM Registration Rights Agreement 1.

The registration statement of which this prospectus forms a part is being filed in part to satisfy our obligations under the DM Registration Rights Agreement 1.

On September 23, 2025, the Company entered into a Warrant Purchase Agreement (the "WPA Investor Purchase Agreement") with five investors (the "WPA Investors"), pursuant to which the Company will offer and sell Class B Ordinary Share purchase warrants to purchase an aggregate of 622,080 Class B Ordinary Shares to the WPA Investors (the "WPA Investor Warrants") for an aggregate of $6,221 (the "WPA Investor Purchase"). The closing of the WPA Investor Purchase occurred simultaneously with the closing of the PIPE Offering. All of the WPA Warrants have been exercised in full on a cashless basis. The Class B Ordinary Shares issued upon the exercise of the WPA Investor Warrants have been included in the registration statement related to this prospectus pursuant to the WPA Investor Registration Rights Agreement (as defined below).

In connection with entering into the WPA Investor Purchase Agreement, on September 23, 2025, the Company and the WPA Investors entered into a Registration Rights Agreement (the "WPA Investor Registration Rights Agreement"), pursuant to which the Company agreed to file a registration statement with the SEC, within 30 days of the closing of the WPA Investor Purchase registering the resale of the Class B Ordinary Shares underlying the WPA Investor Warrant.

The registration statement of which this prospectus forms a part is being filed in part to satisfy our obligations under the WPA Investor Registration Rights Agreement.

On September 23, 2025, the Company entered into a Warrant Purchase Agreement (the "DM Warrant Purchase Agreement") with an entity (the "DM Purchaser") owned and controlled by Mr. McClory pursuant to which the Company will offer and sell a Class B Ordinary Share purchase warrant to purchase 200,000 Class B Ordinary Shares to the DM Purchaser (the "DM Warrant") for $2,000 (the "DM Warrant Purchase"). The closing of the DM Warrant Purchase occurred simultaneously with the closing of the PIPE Offering. The DM Warrant has been exercised in full on a cashless basis. The Class B Ordinary Shares issued upon the exercise of the DM Warrant have been included in the registration statement related to this prospectus pursuant to the DM Registration Rights Agreement 2 (as defined below).

In connection with entering into the DM Warrant Purchase Agreement, on September 23, 2025, the Company and the DM Purchaser entered into a Registration Rights Agreement (the "DM Registration Rights Agreement 2"), pursuant to which the Company agreed to file a registration statement with the SEC, within 30 days of the closing of the DM Warrant Purchase registering the resale of the Class B Ordinary Shares underlying the DM Warrant.

The registration statement of which this prospectus forms a part is being filed in part to satisfy our obligations under the DM Registration Rights Agreement 2.

***Resignations and Appointments of Certain Directors and Officers.***

 

*<u>Resignation of Directors</u>*

Effective September 23, 2025, Dr. Fabio Scacciavillani resigned from the Board of Directors (the "Board") and as Chief Executive Officer of the Company. Dr. Scacciavillani will continue in his role as Chief Financial Officer.

Additionally, on September 23, 2025, Abhishek Matthews, Christopher Gardner, Giuseppe Pirola and Goran Pandev resigned as members of the Board. Neither Mr. Matthew's, Mr. Gardner's, Mr. Pirola's or Mr. Pandev's resignation was a result of any disagreement relating to the Company's operations, policies or practices.

 

*<u>Appointment of Directors</u>*

On September 23, 2025, we appointed the following directors to our board: Dr. Arthur Laffer, Victor Fischer, Keren Maimon, Ron Sade, Alvazi Almheiri and Tarek Alnuaimi. Each of the newly appointed directors will be indemnified by the Company for any claims related to such director being on the Board and will receive annual cash compensation of $200,000 (payable quarterly in $50,000 payments) and equity compensation of 44,444 Class B Ordinary Shares that vest evenly over a period of two years.

 

 

***Employment Agreement with Chief Executive Officer and Director***

 ****

On September 23, 2025, the Company entered into a formal employment agreement (the "Santori Agreement") with Marco Santori pursuant to which Mr. Santori was appointed Chief Executive Officer and a Director of the Company.

Mr. Santori's term as the Company's Chief Executive Officer and Director began on September 23, 2025, and will continue until terminated by either party, subject to the terms of the Santori Agreement (the "Term"). For his services, Mr. Santori will be paid $650,000 annually. Additionally, Mr. Santori will be granted a signing bonus of $1,000,000 and an equity grant of $15,000,000 in restricted stock units which are subject to time and performance based vesting. During the course of the Term, Mr. Santori will be eligible for (i) performance bonuses to be granted at the discretion of the Company's Compensation Committee, (ii) an AUM-based bonus, determined each calendar year based on the Company's SOL AUM as of December 31 of such year, equal to (a) 0.1429% of SOL AUM up to $1,000,000,000, and (b) 0.0714% of any SOL AUM in excess of $1,000,000,000 and (iii) to participate in the Company's 2022 Equity Incentive Plan. The Santori Agreement contains a perpetual confidentiality covenant as well as non-competition and employee and customer non-solicitation covenants that apply during the Term and for a period of one year following Mr. Santori's termination.

***Other Actions Taken in Connection with the PIPE Offering***

● At the closing of the PIPE Offering, the Company redeemed for nominal value 320,000 of the Company's Class A Ordinary Shares, nominal value $0.05 per share, that were held by entities owned and controlled by Daniel J. McClory, a director of the Company;

● At the closing of the PIPE Offering, the Company repaid $2.7 million in notes held by entities owned and controlled by Mr. McClory;

● At the closing of the PIPE Offering, the Company paid Mr. McClory a fee of $4.3 million for his contributions to the PIPE Offering.

● At the closing of the PIPE Offering, 80,000 of the Company's Class A Ordinary Shares were converted into 400,000 Class B Ordinary Shares

● Prior to the closing of the PIPE Offering, Boustead & Company Limited was issued three warrants, each of which have five year terms and cashless exercise, one of which has a number of shares underlying such warrant equal to 5% of the Class B Ordinary Shares issued in the PIPE Offering and an exercise price of $4.50 per share, one of which has a number of shares underlying such warrant equal to 5% of the Class B Ordinary Shares underlying the PIPE Pre-Funded Warrants and an exercise price of $4.45 per share, and one of which has a number of shares underlying such warrant equal to 5% of the Class B Ordinary Shares underlying the PIPE Common Warrants and an exercise price of $6.75 per share.

**Corporate Information**

Our corporate address and registered office are located at Connaught House, 5th Floor, One Burlington Road, Dublin 4, DO4 C5Y6, Ireland. The phone number of our registered office is +353 1 237 3700. Our agent for service of process in the United States is Cogency Global Inc.,122 East 42nd Street, 18th Floor, New York, NY 10168, (800) 221-0102. We maintain a website at www.breraholdings.com. Information available on our website is not incorporated by reference in and is not deemed a part of this prospectus.

**THE OFFERING**

---

| | |
|:---|:---|
| Securities offered by Selling Securityholders: | (A) up to 156,602,916 Class B Ordinary Shares, consisting of (i) 61,505,516 PIPE Shares, (ii) 10,372,130 Strategic Advisor Shares; (iii) 1,000,334 McClory Shares; (iv) 5,858,695 BCL Shares, (v) 93,887 BSL Shares; (vi) 131,821 Series B Conversion Shares; (vii) 785,971 Legacy Shares; (viii) up to 5,161,152 PIPE Pre-Funded Warrant Shares;, (ix) up to 66,666,668 PIPE Warrant Shares; (x) up to 3,333,330 Strategic Advisor Pre-Funded Warrant Shares; (xi) up to 1,666,667 Strategic Advisor Warrant 1 Shares; (xii) 16,000 Series A Conversion Shares and (xiii) 10,745 Legacy Warrant Shares; and (B) warrants to purchase 76,827,817 Class B Ordinary Shares, consisting of (i) the PIPE Pre-Funded Warrants to purchase up to 5,161,152 Class B Ordinary Shares; (ii) the PIPE Common Warrants to purchase up to 66,666,668 Class B Ordinary Shares, (iii) the Strategic Advisor Pre-Funded Warrants to purchase up to 3,333,330 Class B Ordinary Shares and (iv) the Strategic Advisor Common Warrants 1 to purchase up to 1,666,667 Class B Ordinary Shares. |
| Ordinary shares outstanding prior to the offering<sup>1</sup> | 81994765 |
| Ordinary shares outstanding immediately after the offering | 158,849,327, assuming the exercise in full of all PIPE Common Warrants, PIPE Pre-Funded Warrants, Strategic Advisor Warrants and warrants related to the Legacy Warrant Shares and the full conversion of the Series A Preferred Stock. |
| Use of proceeds | We will not receive any of the proceeds from the sale of Class B Ordinary Shares by any Selling Securityholder. However, we will receive up to approximately $461,674,735 in gross proceeds if the PIPE Common Warrants, PIPE Pre-Funded Warrants, Strategic Advisor Warrants and warrants related to the Legacy Warrant Shares are exercised in full (assuming no cashless exercise, as applicable). We intend to use the net proceeds from such exercises for working capital and other general corporate purposes and the pursuit of our new Treasury Policy. We may also use such proceeds to fund acquisitions of businesses, assets or technologies that complement our current business. Our management will retain broad discretion over the allocation of the net proceeds from the exercise of warrants, if any. See "*Use of Proceeds*". |
| Risk factors | Investing in our Class B Ordinary Shares involves a high degree of risk. You should carefully consider all the information in this prospectus and the documents incorporated into each by reference prior to investing in our shares. In particular, we urge you to consider carefully the factors set forth in the section entitled "*Risk Factors*" beginning on page 9 of this prospectus and the documents we have filed with the SEC that are incorporated by reference herein for more information, before you make any investment in our shares. |
| Trading market | Our Class B Ordinary Shares are traded on The Nasdaq Capital Market tier of Nasdaq under the symbol "SLMT". |

---

<sup>1</sup> As of November 17, 2025

**RISK FACTORS**

*An investment in our securities involves a high degree of risk. Before deciding whether to invest in our securities, you should consider carefully the risks described below and discussed under the sections captioned "Risk Factors" contained in our most recent Annual Report on Form 20-F, as filed with the SEC, as well as any amendment or updates to our risk factors reflected in subsequent filings with the SEC, including the risk factors described in Exhibit 99.3 to our Report on Form 6-K, filed with the SEC on September 26, 2025, which are incorporated by reference into this prospectus in their entirety, together with other information in this prospectus and the information and documents incorporated by reference herein, and in any free writing prospectus that we have authorized for use in connection with this offering. If any of these risks actually occurs, our business, financial condition, results of operations or cash flow could be seriously harmed. This could cause the trading price of the Class B Ordinary Shares to decline, resulting in a loss of all or part of your investment.*

**Risks Related to This Offering and Ownership of Our Class B Ordinary Shares**

 ***Our management will have broad discretion as to the use of the proceeds from this offering may invest or otherwise use the proceeds in ways with which you may not agree or in ways that may not yield a return.***

Our management will have broad discretion in the application of the net proceeds from the exercise of the PIPE Common Warrants, PIPE Pre-Funded Warrants and the Strategic Advisor Warrants any additional offering by us and could use the proceeds for purposes other than those contemplated at the time of the offering, including in ways that do not improve our results of operations or enhance the value of our Class B Ordinary Shares. The failure by our management to apply these funds effectively could result in financial losses that have a material adverse effect on our business or cause the price of our Class B Ordinary Shares to decline, delay the development of additional products and services and our pursuit of our new SOL strategy. Pending their use, we may invest the net proceeds from warrant exercises or offerings in a manner that does not produce income or that loses value.

***Future sales of our Class B Ordinary Shares, or the perception in the public markets that these sales may occur, could cause the market price for our Class B Ordinary Shares to decline.***

In order to raise additional capital, we may at any time, including during the pendency of this offering, offer additional Class B Ordinary Shares or other securities convertible into or exchangeable for our Class B Ordinary Shares at prices that may not be the same as the price per share in this offering. We may sell shares or other securities in any other offering at a price per share that is less than the price per share paid by investors in this offering, and investors purchasing shares or other securities in the future could have rights superior to existing stockholders. The price per share at which we sell additional Class B Ordinary Shares, or securities convertible or exchangeable into Class B Ordinary Shares, in future transactions may be higher or lower than the price per share paid by investors in this offering.

In addition, sales of a substantial number of Class B Ordinary Shares in the public market could occur at any time, subject to the restrictions and limitations described below. If our stockholders sell, or the market perceives that our stockholders intend to sell, substantial amounts of our Class B Ordinary Shares in the public market following this offering, the market price of our Class B Ordinary Shares could decline significantly and impair our ability to raise capital through the sale of additional equity securities.

We have reserved 9,000,000 Class B Ordinary Shares for issuance under our 2022 Equity Incentive Plan, and as of the date of this prospectus, we have 1,444,447 Class B Ordinary Shares available shares to be issued. We cannot predict the effect, if any, that market sales of Class B Ordinary Shares or the availability of Class B Ordinary Shares for sale will have on the market price of our Class B Ordinary Shares prevailing from time to time. Sales of substantial amounts of Class B Ordinary Shares in the public market, or the perception that those sales will occur, could cause the market price of our Class B Ordinary Shares.

***We do not expect to pay dividends in the foreseeable future.***

 ****

In the past, we have not paid dividends on our Class B Ordinary Shares. We do not currently intend to pay dividends on our Class B Ordinary Shares and we intend to retain our future earnings, if any, to fund the development and growth of our business. In addition, the terms of future debt agreements may preclude us from paying dividends. As a result, capital appreciation, if any, of our Class B Ordinary Shares may be your sole source of gain for the foreseeable future.

**USE OF PROCEEDS**

We will not receive any of the proceeds from the sale of the Securities by any Selling Securityholder. However, we will receive up to approximately $461,674,735 in gross proceeds if the PIPE Common Warrants, PIPE Pre-Funded Warrants, Strategic Advisor Warrants and the warrants related to the Legacy Warrant Shares are exercised in full (assuming no cashless exercise, as applicable). We intend to use the net proceeds from such exercises for working capital and other general corporate purposes and the pursuit of our new Treasury Policy. We may also use such proceeds to fund acquisitions of businesses, assets or technologies that complement our current business. Our management will retain broad discretion over the allocation of the net proceeds from the exercise of warrants, if any.

**DIVIDEND POLICY**

We have never declared or paid cash dividends on our ordinary shares. We currently intend to retain all available funds and any future earnings for use in the operation of our business and do not anticipate paying any cash dividends in the near future. We may also enter into credit agreements or other borrowing arrangements in the future that will restrict our ability to declare or pay cash dividends. Any future determination to declare dividends will be made at the discretion of our board of directors and will depend on our financial condition, operating results, capital requirements, contractual restrictions, general business conditions and other factors that our board of directors may deem relevant, and will be subject to compliance with applicable laws, including the Irish Companies Act, which requires Irish companies to have distributable reserves available for distribution equal to or greater than the amount of the proposed dividend. In addition, any distribution of dividends must be in accordance with the rules and restrictions applying under Irish law.

**DESCRIPTION OF SHARE CAPITAL**

The description of our authorized share capital and our outstanding securities as of the date of the filing of our Annual Report on Form 20-F for the year ended December 31, 2024 (the "2024 Annual Report") is incorporated by reference to [Exhibit 2.1](https://www.sec.gov/Archives/edgar/data/1939965/000121390025044434/ea024211901ex2-1_brerahold.htm) to the 2024 Annual Report, and supplemented or updated as follows and as updated by our recently amended Constitution, which is contained in Appendix A to our proxy statement that was filed with the SEC on August 29, 2025 as [Exhibit 99.1](https://www.sec.gov/Archives/edgar/data/1939965/000121390025082682/ea0255101-6k_brera.htm) to our Report of Foreign Private Issuer on Form 6-K, which is incorporated by reference:

**General**

The authorized share capital of the Company consists of 10,080,000,000 shares, consisting of (i) 5,000,000 Class A ordinary shares with a nominal value of $0.05 each, (ii) 10,025,000,000 Class B ordinary shares with a nominal value of $0.05 each, and (iii) 50,000,000 preferred shares with a nominal value of $0.005 each of which 10,000,000 are designated as Series A Preferred Shares (the "Series A Preferred Shares") and 2,500,000 are designated as Series B Preferred Shares (the "Series B Preferred Shares").

As of November 17, 2025, there were 20,000 shares of Series A Preferred Stock (convertible into 16,000 Class B Ordinary Shares) outstanding. There are no shares of Series B Preferred Stock outstanding.

**Preferred Shares**

Under our constitution, we are authorized to issue, without shareholder approval, up to 50,000,000 preferred shares, issuable in one or more series, and, subject to the provisions of the Irish Companies Act, having such designations, rights, privileges, restrictions and conditions, including dividend and voting rights, as our board of directors may determine and as further set out in the constitution, and such rights and privileges, including dividend and voting rights, may be superior to those of the ordinary shares. The issuance of preferred shares, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and might adversely affect the market price of our ordinary shares and the voting and other rights of the holders of ordinary shares.

Our board of directors has designated the Series A Preferred Shares and the Series B Preferred Shares (together, the "Designated Preferred Shares"). The voting rights of the Designated Preferred Shares are limited to protective provisions, requiring consent for issuance of senior securities and material adverse amendments. The Designated Preferred Shares rank senior to our ordinary shares in the event of our liquidation, dissolution or winding-up or other distribution of our assets among our shareholders and the holders are entitled to receive an amount per share equal to the original issue price plus any accrued but unpaid dividends before any distribution to the holders of our ordinary shares. The holders of Designated Preferred Shares are entitled to receive dividends as and when recommended and declared by our board of directors or declared by our shareholders on a pari passu basis with our ordinary shares according to the number of Class B Ordinary Shares then issuable to such holders upon conversion of the Designated Preferred Shares. Each Designated Preferred Share is convertible into 0.8 Class B Ordinary Shares at the option of the holder, subject to adjustment as described in its respective certificate of designation. The Series A Preferred Shares are redeemable by us, commencing on the first anniversary of the original issue date, at 150% of the original issue price, payable in cash or Class B Ordinary Shares. The Series B Preferred Shares are not redeemable by us. As of November 17, 2025, there were 20,000 shares of Series A Preferred Stock (convertible into 16,000 Class B Ordinary Shares) outstanding. There are no shares of Series B Preferred Stock outstanding.

Warrants

As of November 17, 2025, the Company had the following outstanding warrants:

● PIPE Common Warrants, exercisable for 66,666,668 Class B Ordinary Shares at an exercise price of $6.75 per share for three years following their initial issuance.

● PIPE Pre-Funded Warrants, exercisable for 5,161,152 Class B Ordinary Shares at an exercise price of $0.05 per share.

● Strategic Advisor Pre-Funded Warrants, exercisable for 3,333,330 Class B Ordinary Shares at an exercise price of $0.05 per share, which are not exercisable until September 23, 2028.

● Strategic Advisor Common Warrants 1, exercisable for 1,666,667 Class B Ordinary Shares at an exercise price of $6.75 per share, which are not exercisable until September 23, 2028.

● Warrants held by certain legacy shareholders to purchase 10,745 Class B Ordinary Shares at an exercise price of $13.50 per share.

RSUs

As of November 17, 2025, the Company has granted 3,555,553 Restricted Stock Units ("RSUs") under the Company's 2022 Equity Incentive Plan as follows:

● On September 23, 2025, our Board of Directors granted Marco Santori, its Director and Chief Executive Officer 3,333,333 RSUs which vest monthly on an even basis over four years. Fifty percent of RSUs vest in five equal 20% tranches upon Company SOL AUM exceeding 1x, 2x, 3x, 4x, and 5x the Private Placement gross proceeds, respectively, on or before the 4th anniversary of grant; remaining 50% vests upon Company raising at least $500,000,000 of equity capital on or before the 4th anniversary of grant. Upon termination by the Company without Cause or by Executive for Good Reason: all unvested time-based RSUs vest in full; performance-based RSUs vest based on actual Company performance for the full performance period (service condition deemed satisfied), payable on the same schedule as for similarly situated executives. 69,444 of these RSUs have vested.

● On September 23, 2025 our Board of Directors granted each of Keren Maimon, Ron Sade, Alyazi Almheiri, Tarek Alnuaimi, Arthur Laffer 44,444 (222,220 in aggregate) RSUs. Each of these RSUs vests in substantially equal quarterly installments over two years commencing from the date of grant, with an initial vesting date on October 23, 2025 (subject to continued service and the Plan). Unvested RSUs accelerate and vest in full upon a Change in Control (as defined in the Plan). 27,777 of these RSUs have vested.

**Transfer Agent**

The transfer agent and registrar for our ordinary shares in the United States is Equiniti Trust Company, 1110 Centre Point Curve, Suite 101, Mendota Heights, MN 55120. Its telephone number is (800) 689-8788.

**Listing**

The Class B Ordinary Shares are listed on The Nasdaq Capital Market tier of Nasdaq under the symbol "SLMT".

**SELLING SECURITYHOLDERS**

The Securities being offered by the Selling Securityholders are those previously issued to the Selling Securityholders, or those issuable upon exercise of previously issued warrants to purchase Class B Ordinary Shares. For additional information regarding the issuances of those Class B Ordinary Shares and the other Securities, see the section of this prospectus titled "Prospectus Summary — Recent Developments — September 2025 PIPE Transaction." We are registering the Securities in order to permit the Selling Securityholders to offer the Securities for resale from time to time.

**Information About the Selling Securityholders**

The following table sets forth, based on information provided to us by or on behalf of the Selling Securityholders or known to us, the name of the Selling Securityholders and the number of Class B Ordinary Shares beneficially owned by the Selling Securityholders before and after this offering.

The table below lists the Selling Securityholders and other information regarding the beneficial ownership (as determined under Section 13(d) of the Exchange Act, and the rules and regulations thereunder) of Class B Ordinary Shares held by each of the Selling Securityholders.

The Selling Securityholders may sell all, some or none of their shares in this offering. See "*Plan of Distribution*." The percentages of ownership of the Selling Securityholders in the below table is based upon 81,994,765 Class B Ordinary Shares outstanding as of November 17, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name of Selling Securityholder** | **Number of<br> Class B Ordinary Shares Owned Prior to Offering<sup>†</sup>** | **Maximum Number of Class B Ordinary Shares to <br> be Sold<br> Pursuant <br> to this<br> Prospectus<sup>†</sup>** | **Number of Class B Ordinary Shares Owned After the Offering<sup>(1)</sup>** | **Percentage Class B Ordinary Shares Owned After the Offering** |
| RBCH Ltd.<sup>(2)</sup> | 22222222 | 22222222 | 0 | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;\* |
| Electric Capital Frontier Fund II, LP<sup>(3)</sup> | 9953142 | 9953142 | 0 | \* |
| Electric Capital Venture Fund III, LP<sup>(4)</sup> | 4146940 | 4146940 | 0 | \* |
| QRT Master Fund SPC- Torus Fund SP<sup>(5)</sup> | 8749714 | 8749714 | 0 | \* |
| Qube Master Fund Ltd<sup>(6)</sup> | 4309562 | 4309562 | 0 | \* |
| ARK Innovation ETF<sup>(7)</sup> | 8632514 | 8632514 | 0 | \* |
| ARK Next Generation Internet ETF<sup>(8)</sup> | 2791382 | 2791382 | 0 | \* |
| ARK FinTech Innovation ETF<sup>(9)</sup> | 1576106 | 1576106 | 0 | \* |
| Anatole Partners Master Fund, L.P.<sup>(10)</sup> | 6332644 | 6332644 | 0 | \* |
| Anatole Partners Enhanced Master Fund, L.P. <sup>(10.1)</sup> | 4778466 | 4778466 | 0 | \* |
| Alyeska Master Fund, LP<sup>(11)</sup> | 10373658 | 10373658 | 0 | \* |
| Gluonfield Holdings Limited<sup>(12)</sup> | 6666668 | 6666668 | 0 | \* |
| V3 Holding Limited<sup>(13)</sup> | 6666666 | 6666666 | 0 | \* |
| Anson Investments Master Fund LP<sup>(14)</sup> | 2888888 | 2888888 | 0 | \* |
| Anson East Master Fund LP<sup>(15)</sup> | 888890 | 888890 | 0 | \* |
| Anson Opportunities Master Fund LP<sup>(16)</sup> | 666666 | 666666 | 0 | \* |
| Black Lines Holdings Limited<sup>(17)</sup> | 4430340 | 4430340 | 0 | \* |
| Meshflow SOL II LLC<sup>(18)</sup> | 2063492 | 2063492 | 0 | \* |
| Bartosz Lipinski | 825396 | 825396 | 0 | \* |
| Funds Managed by Weiss Asset Management LP<sup>(19)</sup> | 2222222 | 2222222 | 0 | \* |
| Phiton Ventures, LLC<sup>(20)</sup> | 2222222 | 2222222 | 0 | \* |
| Off the Chain LP<sup>(21)</sup> | 2222222 | 2222222 | 0 | \* |
| Quantstamp Holdings Bermuda Ltd<sup>(22)</sup> | 2222222 | 2222222 | 0 | \* |
| Arrington XRP Capital Fund, LP<sup>(23)</sup> | 2222222 | 2222222 | 0 | \* |
| OGTM Holdings LLC<sup>(24)</sup> | 1777778 | 1777778 | 0 | \* |
| Origin Capital Partners Limited<sup>(25)</sup> | 222222 | 222222 | 0 | \* |
| Coinfund Liquid Opportunities LP<sup>(26)</sup> | 1268762 | 1268762 | 0 | \* |
| Series F Liquid Opportunities LP<sup>(27)</sup> | 144962 | 144962 | 0 | \* |
| Series G Liquid Opportunities LP<sup>(28)</sup> | 141832 | 141832 | 0 | \* |
| Schonfeld Global Master Fund L.P.<sup>(29)</sup> | 1222222 | 1222222 | 0 | \* |
| Borderless Multi-Strategy Fund V LP<sup>(30)</sup> | 1222222 | 1222222 | 0 | \* |
| Payward, Inc.<sup>(31)</sup> | 888888 | 888888 | 0 | \* |
| Disrupt Investments Limited<sup>(32)</sup> | 888888 | 888888 | 0 | \* |
| Eleven Eleven Algo Ci Ltd<sup>(33)</sup> | 666666 | 666666 | 0 | \* |

---

---

| | | |
|:---|:---|:---|
| CL Advisors - DVII LP<sup>(34)</sup> | 358176 | 0\* |
| CL Advisors - DIII LP<sup>(35)</sup> | 264364 | 0 \* |
| Anagram Ltd.<sup>(36)</sup> | 515228 | 0 \* |
| Paper Group Special Opportunities 2 Inc.<sup>(37)</sup> | 444446 | 0 \* |
| Funicular Funds, LP<sup>(38)</sup> | 444444 | 0 \* |
| Stanislav Oskin | 444444 | 0 \* |
| Ron Sade<sup>(39)</sup> | 2733125 | 0 \* |
| Keren Kalima Maimon<sup>(40)</sup> | 2828679 | 0 \* |
| Dylan Zanker | 111110 | 0 \* |
| Relayer Capital Master Fund Ltd.<sup>(41)</sup> | 111110 | 0 \* |
| Guy Hirsch<sup>(42)</sup> | 2673123 | 6964 \* |
| Eyal Ashur | 44444 | 0 \* |
| Alyazi Saeed Ahmed Alkhattal Almheiri<sup>(43)</sup> | 2562013 | 0 \* |
| Tariq Salem Ebraheem Alsaman Alnuuaimi<sup>(44)</sup> | 5124075 | 0 \* |
| Bevilacqua PLLC<sup>(45)</sup> | 24000 | 0 \* |
| XX Settembre S.r.l.<sup>(46)</sup> | 420000 | 0 \* |
| S.S. Juve Stabia S.r.l.<sup>(47)</sup> | 320000 | 0 \* |
| Arlington Capital Holdings Inc.<sup>(48)</sup> | 16298 | 0 \* |
| Micheal WardIRA<sup>(49)</sup> | 4075 | 0 \* |
| Secure Net Capital LLC<sup>(50)</sup> | 24446 | 0 \* |
| Lotus Investors LLC<sup>(51)</sup> | 8149 | 0 \* |
| UVE Partners LLC<sup>(52)</sup> | 16298 | 0 \* |
| Jelena Jakovljevic<sup>(53)</sup> | 16298 | 0 \* |
| Thomas Saunders<sup>(54)</sup> | 3951 | 0 \* |
| Brenda Fortunate<sup>(55)</sup> | 4075 | 0 \* |
| Brent W. Bost<sup>(56)</sup> | 4075 | 0 \* |
| John Gismondi<sup>(57)</sup> | 4890 | 0 \* |
| Paul T. Barich<sup>(58)</sup> | 10268 | 0 \* |
| John Scott<sup>(59)</sup> | 6275 | 0 \* |
| Samuel Bode Miller<sup>(60)</sup> | 6846 | 0 \* |
| Gregory James Gleason<sup>(61)</sup> | 7656 | 0 \* |
| Charles Wyatt<sup>(62)</sup> | 5705 | 0 \* |
| Jill Jaclin<sup>(63)</sup> | 3261 | 0 \* |
| Oki Enterprises LLC<sup>(64)</sup> | 16000 | 0 \* |
| Boustead Securities, LLC<sup>(65)</sup> | 93887 | 0 \* |
| Brea Holdings LLC<sup>(66)</sup> | 100000 | 0 \* |
| Daniel J. McClory<sup>(67)</sup> | 400000 | 0 \* |
| Pinehurst Partners LLC<sup>(68)</sup> | 500334 | 0 \* |
| Carlton Fiorentino | 44444 | 0 \* |
| Greg Blatt | 888888 | 0 \* |
| Jordan Siberry | 88888 | 0 \* |
| Patrick Loney | 11110 | 0 \* |
| Patrick Murck | 11110 | 0 \* |
| Sony Singh | 222222 | 0 \* |
| Network 1 Financial Securities, Inc.<sup>(69)</sup> | 1395 | 0 \* |
| Michael A. Regina<sup>(70)</sup> | 2788 | 0 \* |
| Patrick N. Teutonico<sup>(71)</sup> | 2788 | 0 \* |
| Robert Chalmers Revocable Trust<sup>(72)</sup> | 90000 | 0 |
| Boustead & Company Limited<sup>(73)</sup> | 5858695 | 0 |
| Genero Fusco<sup>(74)</sup> | 10000 | 0 \* |
| Barolo Aprea<sup>(75)</sup> | 5000 | 0 \* |

---

---

| | |
|:---|:---|
| (\*) | Represents less than 1%. |
| (†). | Unless otherwise provided, 50% of the Class B Ordinary Shares held with respect to each Selling Securityholder represents Class B Ordinary Shares which may be delivered upon exercise of PIPE Common Warrants (which are exercisable within 60 days) held by the respective Selling Securityholder. |
| (1) | Applicable percentage ownership is based on 75,564,159 Class B Ordinary Shares outstanding as of October 15, 2025 |

---

(2) Includes
 (i) 6,500,000 Class B Ordinary Shares, (ii) 4,611,11 Class B Ordinary Shares that are underlying PIPE Pre-Funded Warrants and (iii)
 11,111,111 Class B Ordinary Shares that are underlying PIPE Common Warrants. Mr. Viktor Fischer and Mr. Jakub Havrlant, are the control
 person of the Selling Securityholder, have voting and investment control of the shares held by the Selling Securityholder. Mr. Fischer
 and Mr. Havrlant may be deemed to be the beneficial owner of such shares. Mr. Fischer and Mr. Havrlant, however, disclaims any beneficial
 ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is c/0 Juraj Petro- Rockaway
 X, Generala Piky 430/26, Dejvice, 160 00 Praha 6, Czech Republic.

---

| | |
|:---|:---|
| (3) | Includes (i) 4,588,301 Class B Ordinary Shares, (ii) 388,270 Class B Ordinary Shares that are underlying PIPE Pre-Funded Warrants and (iii) 4,976,571 Class B Ordinary Shares that are underlying PIPE Common Warrants. Curtis Wayne Spencer IV is the Managing Member of Electric Capital Frontier Fund GP II, LLC, the General Partner of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Spencer may be deemed to be the beneficial owner of such shares. Mr. Spencer, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 855 El Camino Real #13A-15, Palo Alto, CA 943012. |
| (4) | Includes (i) 1,911,699 Class B Ordinary Shares, (ii) 161,771 Class B Ordinary Shares that are underlying PIPE Pre-Funded Warrants and (iii) 2,073,470 Class B Ordinary Shares that are underlying PIPE Common Warrants. Curtis Wayne Spencer IV is the Managing Member of Electric Capital Venture Fund GP III, LLC, the General Partner of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Spencer may be deemed to be the beneficial owner of such shares. Mr. Spencer, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 855 El Camino Real #13A-15, Palo Alto, CA 943012. |
| (5) | Stuart Brown, is the Director for Qube Research & Technologies Limited as investment manager for the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Brown may be deemed to be the beneficial owner of such shares. Mr. Brown, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is Suit #7, Grand Pavilion Commercial Centre, 802 West Bay Road, Grand Cayman, KY1-1003, Cayman Islands. |
| (6) | Stuart Brown, is the Director for Qube Research & Technologies Limited as investment manager for the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Brown may be deemed to be the beneficial owner of such shares. Mr. Brown, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is Suit #7, Grand Pavilion Commercial Centre, 802 West Bay Road, Grand Cayman, KY1-1003, Cayman Islands. |
| (7) | Cathie Wood, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Ms. Wood may be deemed to be the beneficial owner of such shares. Ms. Wood, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 200 Central Ave Suite 220, St. Petersburg FL 33701. |
| (8) | Cathie Wood, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Ms. Wood may be deemed to be the beneficial owner of such shares. Ms. Wood, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 200 Central Ave Suite 220, St. Petersburg FL 33701. |
| (9) | Cathie Wood, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Ms. Wood may be deemed to be the beneficial owner of such shares. Ms. Wood, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 200 Central Ave Suite 220, St. Petersburg FL 33701. |
| (10) | The reported securities are directly owned by the Selling Securityholder and may be deemed beneficially owned by Anatole Investment Management Limited ("Anatole") as the investment manager of the Selling Securityholder. The reported securities may also be deemed beneficially owned by Xiaofan Yang as the principal of Anatole. Mr. Yang also may be deemed to be the beneficial owner of such securities. Each of Anatole and Mr. Yang, however, disclaims any beneficial ownership of the securities held by the Selling Shareholder. The address of Selling Securityholder is 17/F Southland Building, 48 Connaught Road Central, Hong Kong. |
| (10.1) | The reported securities are directly owned by the Selling Securityholder and may be deemed beneficially owned by Anatole Investment Management Limited ("Anatole") as the investment manager of the Selling Securityholder. The reported securities may also be deemed beneficially owned by Xiaofan Yang as the principal of Anatole. Mr. Yang also may be deemed to be the beneficial owner of such securities. Each of Anatole and Mr. Yang, however, disclaims any beneficial ownership of the securities held by the Selling Shareholder. The address of Selling Securityholder is 17/F Southland Building, 48 Connaught Road Central, Hong Kong. |
| (11) | Alyeska Investment Group, L.P., the investment manager of Alyeska Master Fund, L.P. the Selling Securityholder has voting and investment control of the shares held by the Selling Securityholder. Anand Parekh is the Chief Executive Officer of Alyeska Investment Group, L.P., and may be deemed to be the beneficial owner of such shares. Mr. Parekh, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The registered address of Alyeska Master Fund, L.P. is at c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, South Church Street George Town, Grand Cayman, KY1-1104, Cayman Islands. Alyeska Investment Group, L.P. is located at 77 W. Wacker, Suite 700, Chicago IL 60601. |
| (12) | Grigori Fishman, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Fishman may be deemed to be the beneficial owner of such shares. Mr. Fishman, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 3<sup>rd</sup> Floor Genesis Building, Genesis Close George Town, PO Box 492, Grand Cayman. |
| (13) | Valerijs Vavilovs, is the Director of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Vavilovs may be deemed to be the beneficial owner of such shares. Mr. Vavilovs, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 4<sup>th</sup> Floor, Harbour Place, 103 South Church Street, P.O. Box 10240, Grand Cayman KY1-1002, George Town, Cayman Islands. |
| (14) | Anson Advisors Inc and Anson Funds Management LP, the Co-Investment Advisers of the Selling Securityholder, hold voting and dispositive power over the Common Shares held by Anson. Tony Moore is the managing member of Anson Management GP LLC, which is the general partner of Anson Funds Management LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc. and may be deemed to be the beneficial owners of such shares, however, Mr. Moore, Mr. Kassam and Mr. Nathoo each disclaim beneficial ownership of these Common Shares except to the extent of their pecuniary interest therein. The principal business address of Anson is Maples Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands |

---

(15) Anson
 Advisors Inc and Anson Funds Management LP, the Co-Investment Advisers of the Selling Securityholder, hold voting and dispositive
 power over the Common Shares held by the Selling Securityholder. Tony Moore is the managing member of Anson Management GP LLC, which
 is the general partner of Anson Funds Management LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc. and may be
 deemed to be the beneficial owners of such shares, however, Mr. Moore, Mr. Kassam and Mr. Nathoo each disclaim beneficial ownership
 of these Common Shares except to the extent of their pecuniary interest therein. The principal business address of Anson is Maples
 Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.

(16) Anson
 Advisors Inc and Anson Funds Management LP, the Co-Investment Advisers of the Selling Securityholder, hold voting and dispositive
 power over the Common Shares held by the Selling Securityholder. Tony Moore is the managing member of Anson Management GP LLC, which
 is the general partner of Anson Funds Management LP. Moez Kassam and Amin Nathoo are directors of Anson Advisors Inc. and may be
 deemed to be the beneficial owners of such shares, however, Mr. Moore, Mr. Kassam and Mr. Nathoo each disclaim beneficial ownership
 of these Common Shares except to the extent of their pecuniary interest therein. The principal business address of Anson is Maples
 Corporate Services Limited, PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.

(17) Shaik
 Zayed Suroor Mohammad Khalifa Alnehayan, is the Director of the Selling Securityholder, has voting and investment control of the
 shares held by the Selling Securityholder. Shaik Zayed Suroor Mohammad Khalifa Alnehayan may be deemed to be the beneficial
 owner of such shares. Shaik Zayed Suroor Mohammad Khalifa Alnehayan , however, disclaims any beneficial ownership of the shares held
 by the Selling Securityholder. The address of the Selling Securityholder is C/O Equus Corporate, Office 2909 BC 9, Floor 29, Tamouh
 Tower, Al Reem Island, Abu Dhabi, UAE.

(18) Bartosz Lipinski, is the control person of the Selling Securityholder,
has voting and investment control of the shares held by the Selling Securityholder. Mr. Lipinski may be deemed to be the beneficial owner
of such shares. Mr. Lipinski, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address
of the Selling Securityholder is 406 N Sangamon 3<sup>rd</sup> Floor, Chicago Il 60642.

(19) Consists of (i) 666,667 Class B Ordinary Shares and 666,667 Class B
Ordinary Shares that are underlying PIPE Common Warrants held by Brookdale Global Opportunity Fund ("BGO") and (ii) 444,444
Class B Ordinary Shares and 444,444 Class B Ordinary Shares that are underlying PIPE Common Warrants held by Brookdale International
Partners, L.P. ("BIP"). Andrew Weiss is the Manager of WAM GP LLC, which is the general partner of Weiss Asset Management
LP, the investment manager of BGO and BIP. WAM GP LLC is also the Manager of BIP GP LLC, the general partner of BIP. Mr. Weiss has voting
and dispositive power with respect to the securities held by BGO and BIP. Mr. Weiss, WAM GP LLC, Weiss Asset Management LP and BIP GP
LLC each disclaim beneficial ownership of the shares held by BGO and BIP, except to the extent of their respective pecuniary interests
therein. The business address of the foregoing entities is c/o Weiss Asset Management, 222 Berkeley Street, 16th Floor, Boston, MA 02116.

(20) Philippe
 Bekhazi is the Chief Executive Officer of the Selling Securityholder, has voting and investment control of the shares held by the
 Selling Securityholder. Mr. Bekhazi may be deemed to be the beneficial owner of such shares. Mr. Bekhazi, however, disclaims any
 beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 2955 NE 7<sup>th</sup>
 Ave Miami FL 33137.

(21) Brian
 Estes, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder.
 Mr. Estes may be deemed to be the beneficial owner of such shares. Mr. Estes, however, disclaims any beneficial ownership of the
 shares held by the Selling Securityholder. The address of the Selling Securityholder is 10337 Los Feliz Dr., Orlando, FL 32836.

(22) Richard Ma, is the Director of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder.
Mr. Ma may be deemed to be the beneficial owner of such shares. Mr. Ma, however, disclaims any beneficial ownership of the shares held
by the Selling Securityholder. The address of the Selling Securityholder is Clarendon House, 2 Church Street, Hamilton HM 11 Bermuda.

(23) J.
 Michael Arrington is the control person of the Selling Securityholder, has voting and investment control of the shares held by the
 Selling Securityholder. Mr. Arrington may be deemed to be the beneficial owner of such shares. Mr. Arrington, however,
 disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is
 382 NE 191st St, Suite 52895, Miami, FL 33179-3899.

(24) Matthew
 Cheng- Yu Liu, is the Managing Member of the Selling Securityholder, has voting and investment control of the shares held by the
 Selling Securityholder. Mr. Liu may be deemed to be the beneficial owner of such shares. Mr. Liu, however, disclaims any beneficial
 ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 4525 Dean Martin DR. 2600,
 Las Vegas, NV 89103.

(25) Matthew
 Cheng- Yu Liu, is the Directo of the Selling Securityholder, has voting and investment control of the shares held by the Selling
 Securityholder. Mr. Liu may be deemed to be the beneficial owner of such shares. Mr. Liu, however, disclaims any beneficial ownership
 of the shares held by the Selling Securityholder. The address of the Selling Securityholder is Craigmuir Chambers, Road Town Tortola,
 VG 1110, British Virgin Islands.

(26) Seth
 Ginns, is the Managing Partner of the Selling Securityholder, has voting and investment control of the shares held by the Selling
 Securityholder. Mr. Ginnsmay be deemed to be the beneficial owner of such shares. Mr. Ginns, however, disclaims any beneficial ownership
 of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 5 Bryant Park Suite 1003, New York,
 NY 10018.

(27) Seth
 Ginns, is the Managing Partner of the Selling Securityholder, has voting and investment control of the shares held by the Selling
 Securityholder. Mr. Ginns may be deemed to be the beneficial owner of such shares. Mr. Ginns, however, disclaims any beneficial ownership
 of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 5 Bryant Park Suite 1003, New York,
 NY 1001.

(28) Seth
 Ginns, is the Managing Parter of the Selling Securityholder, has voting and investment control of the shares held by the Selling
 Securityholder. Mr. Ginns may be deemed to be the beneficial owner of such shares. Mr. Ginns, however, disclaims any beneficial ownership
 of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 5 Bryant Park Suite 1003, New York,
 NY 10018.

(29) Includes
 (i) 611,111 Class B Ordinary Shares and (ii) 611,111 Class B Ordinary Shares that are underlying PIPE Common Warrants. Ran Tolkin,
 CEO and CIO of Schonfeld Strategic Advisors LLC, is the control person of the Selling Securityholder, has voting and investment control
 of the shares held by the Selling Securityholder. Mr. Tolkin may be deemed to be the beneficial owner of such shares. Mr. Tolkin,
 however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder
 is 590 Madison Avenue, 23<sup>rd</sup> Floor, New York, NY 10022.

(30) David
 Garcia, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling
 Securityholder. Mr. Garcia may be deemed to be the beneficial owner of such shares. Mr. Garcia, however, disclaims any beneficial
 ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 4290 South Highway 27 Suite
 201 Space 3 Clermont, FL 34711.

(31) The
 Board of Directors of Payward, Inc., is the control person of the Selling Securityholder, has voting and investment control of the
 shares held by the Selling Securityholder and such voting and investment control is exercised jointly by majority action. Accordingly,
 no individual member of the Board of Directors of Payward, Inc. may be deemed to be the beneficial owner of such shares held by the
 Selling Securityholder. The address of the Selling Securityholder is 1603 Capitol Ave, Suite 517B Cheyenne, WY 82001.

(32) Muhammad Aaqib Gadit, Umair Gadit and Uzair Gadit, are the control persons of the Selling Securityholder, have voting and investment control of the shares held by the Selling Securityholder. Each of, Muhammad Aaqib Gadit, Umair Gadit, and Uzair Gadit may be deemed to be the beneficial owner of such shares. Muhammad Aaqib Gadit, Umair Gadit, and Uzair Gadit, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is Unit 16, Level 15, The Gate, East, Dubai International Financial Centre Dubai, United Arab Emirates.

(33) Arul Murugan, is the Managing Director of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Murugan may be deemed to be the beneficial owner of such shares. Mr. Murugan, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 1151 S Alhambra Circle Coral Gables, FL 33146.

(34) Sebastian Evans, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Evans may be deemed to be the beneficial owner of such shares. Mr. Evans, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 333 Bush Street, 4th Floor, San Francisco, CA 94104 .

(35) Sebastian Evans, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Evans may be deemed to be the beneficial owner of such shares. Mr. Evans, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 333 Bush Street, 4th Floor, San Francisco, CA 94104 .

(36) Joseph Eagan and Lily Yuan-Li Liu, are the control persons of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Eagan and Ms. Yuan-Li Liu may be deemed to be the beneficial owner of such shares. Mr. Eagan and Ms. Yuan-Li Liu, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 10 Market Street, Unit #2462, Camana Bay, Cayman Islands KY19006 .

(37) Danish Chaudhry, is the Director of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Chaudhry may be deemed to be the beneficial owner of such shares. Mr. Chaudhry, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is P.O. Box 71 C/O Craigmuir Chambers Road Town, Tortola VG 1110.

(38) Jacob Ma-Weaver, is the Managing Member of the General Partner of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Ma-Weaver may be deemed to be the beneficial owner of such shares. Mr. Ma-Weaver, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 601 California Street, Suite 1151, San Francisco, CA 94108.

(39) Includes (i) 1,899,792 Class B Ordinary Shares, (ii) 171,112 Class
B Ordinary Shares underlying PIPE Common Warrants, (iii) 555,555 Class B Ordinary Shares underlying Strategic Advisor Pre-Funded Warrants;
and (iv) 277,778 Class B Ordinary Shares underlying Strategic Advisor Common Warrants 1.

(40) Includes (i) 1,862,013 Class B Ordinary Shares, (ii) 133,333 Class
B Ordinary Shares that are underlying PIPE Common Warrants, (iii) 555,555 Class B Ordinary Shares underlying Strategic Advisor Pre-Funded
Warrants; and (iv) 277,778 Class B Ordinary Shares underlying Strategic Advisor Common Warrants 1.

(41) Austin Barack, is the Director of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Barack may be deemed to be the beneficial owner of such shares. Mr. Barack, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 4<sup>th</sup> Floor, Harbour Place, 103 South Church Street, Grand Cayman, KY1-1002, Cayman Islands.

(42) Includes (i) 1,784,235 Class B Ordinary Shares, (ii) 55,555 Class B
Ordinary Shares that are underlying PIPE Common Warrants, (iii) 555,555 Class B Ordinary Shares underlying Strategic Advisor Pre-Funded
Warrants; and (iv) 277,778 Class B Ordinary Shares underlying Strategic Advisor Common Warrants 1.

(43) Includes (i) 1,728,680 Class B Ordinary Shares, (ii) 555,555 Class
B Ordinary Shares underlying Strategic Advisor Pre-Funded Warrants; and (iii) 277,778Class B Ordinary Shares underlying Strategic Advisor
Common Warrants 1.

(44) Includes (i) 3,457,410 Class B Ordinary Shares, (ii) 1,111,110 Class
B Ordinary Shares underlying Strategic Advisor Pre-Funded Warrants; and (iii) 555,555 Class B Ordinary Shares underlying Strategic Advisor
Common Warrants 1.

(45) Consists of 24,000 Class B Ordinary Shares. Louis Bevilacqua, is the Member of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Bevilacqua may be deemed to be the beneficial owner of such shares. Louis Bevilacqua, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 1050 Connecticut Ave, NW, Suite 500, Washington, DC 20036.

(46) Consists of 420,000 Class B Ordinary Shares. Andrea Langella, is the control person of the Selling Securityholder, has voting and investment control over the shares held by the Selling Securityholder, Ms. Langella, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is Via posillipo n.9 80123 Napoli Italy.

(47) Consists of 320,000 Class B Ordinary Shares. Filippo Polcino, is the control person of the Selling Securityholder, has voting and investment control over the shares held by the Selling Securityholder, Mr. Polcino, however, disclaims any beneficia ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 118 Arlington Avenue, Westmount, Quebec H3Y2W4.

(48) Includes (i) 14,816 Class B Ordinary Shares and (ii) 1,482 Class B Ordinary Shares underlying warrants. Mark Nawacki, is the President of the Selling Securityholder, has voting and investment control over the shares held by the Selling Securityholder, Mr. Nawacki, however, disclaims any beneficia ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is Via G. DE MARCO N. 31 PAUPISI - BN -ITALY.

(49) Includes (i) 3,704 Class B Ordinary Shares and (ii) 371 Class B Ordinary Shares underlying warrants. Michael Ward, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Pacific Premier Trust Cust IRA FBO Micael Verne Ward may be deemed to be the beneficial owner of such shares. Michael Ward, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is PO Box 981012, Boston, MA 02298.

(50) Consists
 of 24,446 Class B Ordinary Shares. Al Rubenbauer, is the Managing Partner of the Selling Securityholder, has voting and investment
 control of the shares held by the Selling Securityholder. Mr, Rubenbauermay be deemed to be the beneficial owner of such shares.
 Mr. Rubenbauer, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the
 Selling Securityholder is PO Box 981012, Boston, MA 02298.

(51) Includes
 (i) 7,408 Class B Ordinary Shares and (ii) 741 Class B Ordinary Shares underlying warrants. Howard Rubin, is the control person of
 the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Rubin may be
 deemed to be the beneficial owner of such shares. Mr. Rubin, however, disclaims any beneficial ownership of the shares held by the
 Selling Securityholder. The address of the Selling Securityholder is 23 Lotus Street, Cedarhurst, NY 11516

(52) Includes
 (i) 14,816 Class B Ordinary Shares and (ii) 1,482 Class B Ordinary Shares underlying warrants. Gary Simon, is the Managing Member
 of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Mr. Simon may
 be deemed to be the beneficial owner of such shares. Mr. Simon, however, disclaims any beneficial ownership of the shares held by
 the Selling Securityholder. The address of the Selling Securityholder is 23 Lotus Street, Cedarhurst, NY 11516.

(53) Includes
 (i) 14,816 Class B Ordinary Shares and (ii) 1,482 Class B Ordinary Shares underlying warrants.

(54) Includes
 (i) 3,591 Class B Ordinary Shares and (ii) 360 Class B Ordinary Shares underlying warrants.

(55) Includes
 (i) 3,704 Class B Ordinary Shares and (ii) 371 Class B Ordinary Shares underlying warrants.

(56) Includes
 (i) 3,704 Class B Ordinary Shares and (ii) 371 Class B Ordinary Shares underlying warrants.

(57) Includes
 (i) 4,445 Class B Ordinary Shares and (ii) 445 Class B Ordinary Shares underlying warrants.

(58) Includes
 (i) 9,334 Class B Ordinary Shares and (ii) 934 Class B Ordinary Shares underlying warrants.

(59) Includes
 (i) 5.704 Class B Ordinary Shares and (ii) 571 Class B Ordinary Shares underlying warrants.

(60) Includes
 (i) 6,223 Class B Ordinary Shares and (ii) 623 Class B Ordinary Shares underlying warrants.

(61) Includes
 (i) 6,960 Class B Ordinary Shares and (ii) 696 Class B Ordinary Shares underlying warrants.

(62) Includes
 (i) 5,186 Class B Ordinary Shares and (ii) 519 Class B Ordinary Shares underlying warrants.

(63) Includes
 (i) 2,964 Class B Ordinary Shares and (ii) 297 Class B Ordinary Shares underlying warrants.

(64) Consists of 16,000 Class B Ordinary Shares that are issuable upon conversion
of 20,000 shares of Series A Preferred Stock. Scott Oki, is the control person of the Selling Securityholder, has voting and investment
control of the shares held by the Selling Securityholder. Mr. Oki may be deemed to be the beneficial owner of such shares. Mr. Oki, however,
disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 4315
Hunts Point Rd, Hunts Point, WA 98004.

(65) Consists
 of 78,888 Class B Ordinary Shares. Daniel J. McClory, the control person of the Selling Securityholder, has voting and investment
 control of the shares held by the Selling Securityholder. Mr. McClory may be deemed to be the beneficial owner of such shares. Mr.
 McClory, however, disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling
 Securityholder is 6 Venture Suite 395, Irvine, CA 92618. Mr. McClory is an executive Director of the Company.

(66) Consists
 of 100,000 Class B Ordinary Shares. Daniel J. McClory, the Managing Member of the Selling Securityholder, has voting and investment
 control of the shares held by the Selling Securityholder. The address of the Selling
 Securityholder is 318 N. Carson Street, Suite 208, Carson City, NV 8970. Mr. McClory is an executive Director of the Company.

(67) Consists
 of 400,000 Class B Ordinary Shares. Mr. McClory is an executive Director of the Company.

(68) Consists
 of 500,334 Class B Ordinary Shares. Daniel J. McClory, the President of the Selling Securityholder, has voting and investment control
 of the shares held by the Selling Securityholder. The address of the Selling Securityholder
 is 6525 Gunpark Drive, Suite 370-103, Boulder, CO 80301. Mr. McClory is an executive Director of the Company.

(69) Consists of 1,395 Class B Ordinary Shares. William R. Hunt, Jr., is the
President of the Selling Securityholder, has voting and investment control of the shares held by the Selling Securityholder. Hunt may
be deemed to be the beneficial owner of such shares. Mr. Hunt, however, disclaims any beneficial ownership of the shares held by the Selling
Securityholder. The address of the Selling Securityholder is 7829 Aberdeen Rd, Bethesda, MD 20814

(70) Consists of 2,788 Class B Ordinary Shares.

(71) Consists of 2,788 Class B Ordinary Shares.

(72) Robert
 Chalmers, is the control person of the Selling Securityholder, has voting and investment control of the shares held by the Selling
 Securityholder. Mr. Chalmers may be deemed to be the beneficial owner of such shares. Mr. Chalmers, however, disclaims any beneficial
 ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is 910 Lugo Ave, Coral Gables,
 FL 33156

(73) Consists
 of 5,858,695 Class B Ordinary Shares. Keith Moore, the President of the Selling Securityholder, has voting and investment control
 of the shares held by the Selling Securityholder. Mr. Moore may be deemed to be the beneficial owner of such shares. Mr. Moore, however,
 disclaims any beneficial ownership of the shares held by the Selling Securityholder. The address of the Selling Securityholder is
 6 Venture, Suite 395, Irvine CA, 92618.

(74) Consists of 10,000 Class B Ordinary Shares.

(75) Consists of 5,000 Class B Ordinary Shares.

**PLAN OF DISTRIBUTION**

Each Selling Securityholder and any of their pledgees, donees, transferees, assignees, and other successors-in-interest may, from time to time, sell any or all of their securities covered hereby on the principal trading market or any other stock exchange, market or trading facility on which the Securities are traded or in private transactions. These sales may be at fixed or negotiated prices. The Selling Securityholders will act independently of us in making decisions with respect to the timing, manner and size of each sale. Such sales may be made on one or more exchanges or in the over-the-counter market or otherwise, at prices and under terms then prevailing or at prices related to the then current market price or in negotiated transactions. The Selling Securityholders reserve the right to accept and, together with their respective agents, to reject, any proposed purchase of securities to be made directly or through agents. The Selling Securityholders and any permitted transferees may sell their securities offered by this prospectus on any stock exchange, market or trading facility on which the securities are traded or in private transactions. A Selling Securityholder may use any one or more of the following methods when selling securities:

● through brokers or dealers (who may act as agent or principal and who may receive compensation in the form of discounts, concessions or commissions from such Selling Securityholder, the purchaser or such other persons who may be effecting such sales, which discounts, concessions or commissions as to any particular broker or dealer may be in excess of those customary to the types of transactions involved) for resale to the public or to institutional investors at various times;

● through negotiated transactions, including, but not limited to, block trades in which the broker or dealer so engaged will attempt to sell the shares as agent but may position and resell a portion of the block as principal to facilitate the transaction;

● through purchases by a broker or dealer as principal and resale by that broker or dealer for its account;

● on any national securities exchange or quotation service on which the shares may be listed or quoted at the time of sale at market prices prevailing at the time of sale, at prices related to such prevailing market prices, or at negotiated prices;

● in privately negotiated transactions other than exchange or quotation service transactions;

● short sales, purchases or sales of put, call or other types of options, forward delivery contracts, swaps, offerings of structured equity-linked securities or other derivative transactions or securities;

● hedging transactions, including, but not limited to:

● transactions with a broker-dealer or its affiliate, whereby the broker-dealer or its affiliate will engage in short sales of shares and may use shares held by such Selling Securityholder to close out its short position;

● options or other types of transactions that require the delivery of shares to a broker-dealer or an affiliate thereof, who will then resell or transfer the shares; or

● loans or pledges of shares to a broker-dealer or an affiliate, who may sell the loaned shares or, in an event of default in the case of a pledge, sell the pledged shares;

● through offerings of securities exercisable, convertible or exchangeable for shares, including, without limitation, securities issued by trusts, investment companies or other entities;

● offerings directly to one or more purchasers, including institutional investors;

● through ordinary brokerage transactions and transactions in which a broker solicits purchasers;

● through distribution to the security holders of the Selling Securityholder;

● by pledge to secure debts and other obligations;

● through a combination of any such methods of sale; or

● through any other method permitted under applicable law.

The Selling Securityholders may also sell securities under Rule 144 under the Securities Act ("Rule 144") or any other exemption from registration under the Securities Act, if available, rather than under this prospectus.

There can be no assurance that any Selling Securityholder will sell any or all of the Class B Ordinary Shares registered pursuant to the registration statement of which this prospectus forms a part.

In addition, a Selling Securityholder that is an entity may elect to make an in-kind distribution of securities to its members, partners or stockholders pursuant to the registration statement of which this prospectus is a part by delivering a prospectus with a plan of distribution. Such members, partners or stockholders would thereby receive freely tradeable securities pursuant to the distribution through a registration statement. To the extent a distributee is an affiliate of ours (or to the extent otherwise required by law), we may file a prospectus supplement in order to permit the distributees to use the prospectus to resell the securities acquired in the distribution.

The Selling Securityholders also may transfer the securities in other circumstances, in which case the transferees, pledgees or other successors-in-interest will be the selling beneficial owners for purposes of this prospectus. Upon being notified by the Selling Securityholders that a donee, pledgee, transferee, other successor-in-interest intends to sell our securities, we will, to the extent required, promptly file a supplement to this prospectus to name specifically such person as a Selling Securityholder.

Broker-dealers engaged by the Selling Securityholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or discounts from the Selling Securityholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in excess of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown in compliance with FINRA Rule 2121.

In connection with the sale of the securities or interests therein, the Selling Securityholders may enter into hedging transactions with broker-dealers or other financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume. The Selling Securityholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Securityholders may also enter into option or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).

The Selling Securityholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be "underwriters" within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act. Each Selling Securityholder has informed the Company that it does not have any written or oral agreement or understanding, directly or indirectly, with any person to distribute the securities.

We are required to pay certain fees and expenses incurred by the Company incident to the registration of the Securities. The Company has agreed to indemnify the Selling Securityholders against certain losses, claims, damages and liabilities, including liabilities under the Securities Act. The Company shall not be responsible for any of the Selling Securityholders' selling costs incurred pursuant to any available method provided hereunder for selling securities.

With respect to the PIPE Shares, PIPE Pre-Funded Warrants, PIPE Pre-Funded Warrant Shares, PIPE Common Warrants, PIPE Warrant Shares, Strategic Advisor Warrants, and Strategic Advisor Warrant Shares (other than the Strategic Advisor Warrant Shares issued upon the exercise of the WPA Investor Warrants), we are obligated to maintain the effectiveness of this registration statement until such Securities (i) have been sold, hereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144. The resale securities will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. With respect to the McClory Shares and the Strategic Advisor Warrant Shares that were issued upon exercise of the WPA Investor Warrants, we are obligated to maintain the effectiveness of this registration statement until the earlier of the date (i) such Securities have been sold or (ii) that is two years from the closing date of the PIPE Offering. In addition, in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement is available and is complied with.

Under applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously engage in market making activities with respect to the Class B Ordinary Shares for the applicable restricted period, as defined in Regulation M, prior to the commencement of the distribution. In addition, the Selling Securityholders will be subject to applicable provisions of the Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the Class B Ordinary Shares by the Selling Securityholders or any other person. We will make copies of this prospectus available to the Selling Securityholders and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including by compliance with Rule 172 under the Securities Act).

**LEGAL MATTERS**

The validity of the issuance of the Class B Ordinary Shares covered by this prospectus, the PIPE Pre-Funded Warrants, PIPE Common Warrants, and Strategic Advisor W arrants, and certain other legal matters as to Irish law will be passed upon for us by Clark Hill Solicitors LLP, Dublin, Ireland. Certain other legal matters relating to U.S. federal law and the laws of the State of New York will be passed upon for us by Sichenzia Ross Ference Carmel LLP who may also rely upon Clark Hill Solicitors LLP with respect to matters governed by Irish law.

**EXPERTS**

The audited consolidated financial statements as of December 31, 2024, incorporated herein by reference from the 2024 [Annual Report](https://www.sec.gov/Archives/edgar/data/1939965/000121390025048029/ea0242667-20fa1_brerahold.htm), have been audited by Reliant CPA PC, an independent registered public accounting firm, as stated in its report, which is incorporated by reference and has been so incorporated in reliance upon the report of such firm given upon its authority as experts in accounting and auditing.

The audited consolidated financial statements as of December 31, 2023 and 2022, and for each of the years in the two-year period ended December 31, 2023, incorporated herein by reference from the 2024 [Annual Report](https://www.sec.gov/Archives/edgar/data/1939965/000121390025048029/ea0242667-20fa1_brerahold.htm), have been audited by TAAD LLP, an independent registered public accounting firm, as stated in its report, which is incorporated by reference and has been so incorporated in reliance upon the report of such firm given upon its authority as experts in accounting and auditing. In September 2024, TAAD LLP became the predecessor auditor.

The audited financial statements of Società Sportiva Juve Stabia s.r.l.incorporated by reference in this prospectus and elsewhere in the registration statement have been incorporated by reference in reliance upon the report of RIA Grant Thornton SPA, independent auditors, upon the authority of said firm as experts in accounting and auditing

**WHERE YOU CAN FIND MORE INFORMATION**

This prospectus is registering the securities that may be offered and sold hereunder. For further information about us and the securities offered hereby, reference is made to the registration statement, the exhibits filed therewith and the documents incorporated by reference therein. Statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and in each instance, we refer you to the copy of such contract or other document filed as an exhibit to the registration statement. We are required to file reports and other information with the SEC pursuant to the Exchange Act, including annual reports on Form 20-F and reports on Form 6-K.

The SEC maintains a website that contains reports and other information regarding issuers, like us, that file electronically with the SEC. The address of the website is www.sec.gov. The information on our website (https://www.breraholdings.com), other than our SEC filings, is not, and should not be, considered part of this prospectus and is not incorporated by reference into this document.

As a foreign private issuer, we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short-swing profit recovery provisions contained in Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act.

**INCORPORATION OF CERTAIN INFORMATION BY REFERENCE**

The SEC allows us to "incorporate by reference" the information we file with it into this prospectus. This means that we can disclose important information about us and our financial condition to you by referring you to another document filed separately with the SEC instead of having to repeat the information in this prospectus. The information incorporated by reference is considered to be part of this prospectus and later information that we file with the SEC will automatically update and supersede this information. We incorporate by reference into this prospectus the information contained in the documents listed below and any future filings made by us with the SEC under Section 13(a), 13(c) or 15(d) of the Exchange Act, except for information "furnished" to the SEC which is not deemed filed and not incorporated by reference into this prospectus (unless otherwise indicated below), until the termination of the offering of securities described in the applicable prospectus supplement:

● the Company's Annual Report on [Form 20-F](https://www.sec.gov/Archives/edgar/data/1939965/000121390025044434/ea0242119-20f_brerahold.htm) for the fiscal year ended December 31, 2024, filed with the SEC on May 15, 2025, and the Amendment No. 1 to the Annual Report on [Form 20-F](https://www.sec.gov/Archives/edgar/data/1939965/000121390025048029/ea0242667-20fa1_brerahold.htm) for the fiscal year ended December 31, 2024, filed with the SEC on May 28, 2025;

● the Company's Reports on Form 6-K furnished to the SEC on [January 2, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390024114140/ea0226240-6k_brera.htm) , [January 7, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025001619/ea0227000-6k_brerahold.htm) , [January 10, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025002739/ea0227399-6k_brerahold.htm) , [January 15, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025003893/ea022783401-6k_brera.htm) , [February 7, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025011337/ea022997201-6k_brera.htm) , [February 13, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025013174/ea0230878-6k_brera.htm) , [February 21, 2025](http://www.sec.gov/Archives/edgar/data/1939965/000121390025016137/ea023181001-6k_brerahold.htm) , [March 3, 2025](http://www.sec.gov/Archives/edgar/data/1939965/000121390025019382/ea0232627-6k_brera.htm) , [March 7, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025021358/ea0233513-6k_brera.htm) , [March 31, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025026209/ea023612101-6k_brerahold.htm) , [April 1, 2025,](https://www.sec.gov/Archives/edgar/data/1939965/000121390025027156/ea0236583-6k_brera.htm) [May 23, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025047427/ea0243305-6k_brera.htm) , [June 4, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025051235/ea0244718-6k_brera.htm) , [June 10, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025053067/ea0245161-6k_brera.htm) , [June 16, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025054459/ea0245801-6k_brera.htm) , [June 17, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025055240/ea0245980-6k_brera.htm) , [June 23, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025056681/ea0246530-6k_brera.htm) , [June 23, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025056701/ea0246525-6k_brera.htm) , [June 24, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025056896/ea0246577-6k_brera.htm) , [July 14, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025063482/ea0248812-6k_brera.htm) , [August 29, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025082682/ea0255101-6k_brera.htm) , [September 5, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025085112/ea0256149-6k_brera.htm) , [September 18, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025088821/ea0257850-6k_brera.htm) , [September 18, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025088973/ea0257856-6k_brera.htm) , [September 26, 2025](http://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea0258532-6k_brera.htm) , [October 22, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025101244/ea0262139-6k_brera.htm) and [October 27, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025102293/ea0259489-6k_brera.htm) ; and

● the description of the Company's Class B Ordinary Shares contained in the Company's Registration Statement on [Form 8-A](https://www.sec.gov/Archives/edgar/data/1939965/000121390023005272/ea172255-8a12b_brera.htm) (File No. 001-41606) filed with the SEC on January 26, 2023, pursuant to Section 12(b) of the Exchange Act, including any amendment or report filed for the purpose of updating such description.

We also incorporate by reference any future annual reports on Form 20-F we file with the SEC under the Exchange Act after the date of this prospectus and prior to the termination of the offering of securities by means of this prospectus, and any future reports of foreign private issuer on Form 6-K we furnish with the SEC during such period that are identified in such reports as being incorporated by reference in this prospectus.

Any reports filed by us with the SEC after the date of this prospectus and before the date that the offering of securities by means of this prospectus is terminated will automatically update and, where applicable, supersede any information contained in this prospectus or incorporated by reference in this prospectus. This means that you must look at all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any documents incorporated by reference have been modified or superseded. Unless expressly incorporated by reference, nothing in this prospectus shall be deemed to incorporate by reference information furnished to, but not filed with, the SEC.

We will provide without charge to any person (including any beneficial owner) to whom this prospectus is delivered, upon oral or written request, a copy of any document incorporated by reference in this prospectus but not delivered with the prospectus (except for exhibits to those documents unless a document states that one of its exhibits is incorporated into the document itself). Such request should be directed to: Brera Holdings PLC, Connaught House, 5th Floor, One Burlington Road, Dublin 4, DO4 C5Y6, Ireland, and telephone number +353 1 237 3700.

![](image_001.jpg)

**BRERA HOLDINGS PLC**

**79,748,354 Class B Ordinary Shares**

**PIPE Pre-Funded Warrants to Purchase up to 5,161,152 Class B Ordinary Shares**

**5,161,152 Class B Ordinary Shares Underlying the PIPE Pre-Funded Warrants**

**PIPE Common Warrants to Purchase up to 66,666,668 Class B Ordinary Shares**

**66,666,668 Class B Ordinary Shares Underlying PIPE Common Warrants**

**Strategic Advisor Pre-Funded Warrants to Purchase up to 3,333,330 Class B Ordinary Shares**

**3,333,330 Class B Ordinary Shares Underlying Strategic Advisor Pre-Funded Warrants**

**Strategic Advisor Common Warrants 1 to Purchase up to 1,666,667 Class B Ordinary Shares**

**1,666,667 Class B Ordinary Shares Underlying Strategic Advisor Common Warrants 1**

**10,745 Class B Ordinary Shares Underlying Warrants**

**16,000 Class B Ordinary Shares Underlying Series A Preferred Stock**

**PROSPECTUS**

**November 19, 2025**

**PART II**

**INFORMATION NOT REQUIRED IN THE PROSPECTUS**

**Item 8. Indemnification of Directors and Officers.**

To the fullest extent permitted by Irish law, our constitution (which will be substantially in the form attached as Exhibit 3.1 to this registration statement) will confer an indemnity on our directors and officers. However, this indemnity is limited by the Irish Companies Act, which prescribes that an advance commitment to indemnify only permits a company to pay the costs or discharge the liability of a director or corporate secretary where judgment is given in favor of the director or corporate secretary in any civil or criminal action in respect of such costs or liability, or where an Irish court grants relief because the director or corporate secretary acted honestly and reasonably and ought fairly to be excused. Any provision whereby an Irish company seeks to commit in advance to indemnify its directors or corporate secretary over and above the limitations imposed by the Irish Companies Act will be void under Irish law, whether contained in its constitution or any contract between the company and the director or corporate secretary. This restriction does not apply to our executives who are not directors or other persons who would not be considered "officers" within the meaning of that term under the Irish Companies Act. Our constitution will also contain indemnification and expense advancement provisions for persons who are not directors or our corporate secretary.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

At present, there is no pending litigation or proceeding involving any of our directors or officers where indemnification will be required or permitted. We are not aware of any threatened litigation or proceeding that might result in a claim for such indemnification.

**Item 9. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 2.1 | [Description of Securities Pursuant to Section 12 of the Exchange Act as of December 31, 2024 (incorporated by reference to Exhibit 2.1 to Annual Report on Form 20-F filed on May 15, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025044434/ea024211901ex2-1_brerahold.htm) |
| 2.2 | [Subscription Agreement and Certificate of Designation of Series A Preferred Shares (incorporated by reference to Exhibit 1.1 to Form 6-K filed on December 27, 2024)](https://www.sec.gov/Archives/edgar/data/1939965/000121390024113168/ea022619801ex1-1_brera.htm) |
| 2.3 | [Amendment No. 1 to Certificate of Designation of Preferences, Benefits and Limitations of Series A Preferred Shares (Incorporated by reference to Exhibit 2.5 to Form 20-F filed on May 15, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025044434/ea024211901ex2-5_brerahold.htm) |
| 3.1 | [Constitution of the Registrant (incorporated by reference to Exhibit 3.1 filed on Form 6-K, filed on September 26, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex3-1_brera.htm) |
| 4.1 | [Form of PIPE Pre-Funded Warrant (Incorporated by reference to Exhibit 4.1 filed on Form 6-K September 18, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025088821/ea025785001ex4-1_brera.htm) |
| 4.2 | [Form of PIPE Common Warrant Agreement (Incorporated by reference to Exhibit 4.2 filed on Form 6-K September 18, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025088821/ea025785001ex4-2_brera.htm) |
| 4.3 | [Form of Strategic Advisor Pre-Funded Warrant (Incorporated by reference to Exhibit 4.3 filed on Form 6-K September 25, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex4-3_brera.htm) |
| 4.4 | [Form of Strategic Advisor Common Warrant 1 (Incorporated by reference to Exhibit 4.4 filed on Form 6-K September 25, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex4-4_brera.htm) |
| 4.5 | [Form of Strategic Advisor Common Warrant 2 (Incorporated by reference to Exhibit 4.5 filed on Form 6-K September 25, 2025)](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex4-5_brera.htm) |

---

---

| | |
|:---|:---|
| 4.6 | [Second Amendment to Brera Holdings Public Limited 2022 Equity Incentive Plan](ea026111501ex4-6_brera.htm) |
| 5.1 | [Legal Opinion of Clark Hill Solicitors LLP](ea026111501ex5-1_brera.htm) |
| 5.2 | [Legal Opinion of Sichenzia Ross Ference Carmel LLP](ea026111501ex5-2_brera.htm) |
| 10.1 | [Form of Securities Purchase Agreement, dated as of September 18, 2025, between Brera Holdings PLC and each Purchaser (as defined therein) (Incorporated by reference to Exhibit 10.1 filed on Form 6-K September 18, 2025)](http://www.sec.gov/Archives/edgar/data/1939965/000121390025088821/ea025785001ex10-1_brera.htm) |
| 10.2 | [Form of Registration Rights Agreement, dated as of September 18, 2025, between Brera Holdings PLC and each Holder (as defined therein) (Incorporated by reference to Exhibit 10.2 filed on Form 6-K September 18, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025088821/ea025785001ex10-2_brera.htm) |
| 10.3 | [Employment Agreement with Marco Santori, effective September 23, 2025 (Incorporated by reference to Exhibit 10.3 filed on Form 6-K September 25, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-3_brera.htm) |
| 10.4 | [Strategic Advisor Agreement, dated September 18, 2025 (Incorporated by reference to Exhibit 10.4 filed on Form 6-K September 26, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-4_brera.htm) |
| 10.5 | [Investor Warrant Purchase Agreement, dated September 23, 2025 (Incorporated by reference to Exhibit 10.5 filed on Form 6-K September 26, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-5_brera.htm) |
| 10.6 | [Investor Registration Rights Agreement, dated September 23, 2025 (Incorporated by reference to Exhibit 10.6 filed on Form 6-K September 26, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-6_brera.htm) |
| 10.7 | [DM Warrant Purchase Agreement, dated September 23, 2025 (Incorporated by reference to Exhibit 10.7 filed on Form 6-K September 26, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-7_brera.htm) |
| 10.8 | [DM Registration Rights Agreement 1, dated September 23, 2025 (Incorporated by reference to Exhibit 10.8 filed on Form 6-K September 26, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-8_brera.htm) |
| 10.9 | [Form of Indemnification Agreement (Incorporated by reference to Exhibit 10.9 filed on Form 6-K September 25, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-9_brera.htm) |
| 10.1 | [DM Registration Rights Agreement 2, dated September 23, 2025 (Incorporated by reference to Exhibit 10.10 filed on Form 6-K September 26, 2025](https://www.sec.gov/Archives/edgar/data/1939965/000121390025091823/ea025853201ex10-10_brera.htm) |
| 10.11 | [Employment Agreement with Justin Bowes, effective November 4, 2025 (Incorporated by reference to Exhibit 10.1 filed on Form 6-K November 7, 2025).](http://www.sec.gov/Archives/edgar/data/1939965/000121390025107601/ea026439101ex10-1_brera.htm) |
| 10.12 | [Employment Agreement with Alberto Libanori, effective November 4, 2025 (Incorporated by reference to Exhibit 10.1 filed on Form 6-K November 13, 2025).](http://www.sec.gov/Archives/edgar/data/1939965/000121390025110055/ea026543801ex10-1_brera.htm) |
| 23.1 | [Consent of TAAD LLP](ea026111501ex23-1_brera.htm) |
| 23.2 | [Consent of Reliant CPA PC](ea026111501ex23-2_brera.htm) |
| 23.3 | [Consent of Grant Thorton S.p.A.](ea026111501ex23-3_brera.htm) |
| 23.4 | [Consent of Clark Hill Solicitors LLP (included in Exhibit 5.1)](ea026111501ex5-1_brera.htm) |
| 23.5 | [Consent of Sichenzia Ross Ference Carmel LLP (included in Exhibit 5.2)](ea026111501ex5-2_brera.htm) |
| 24.1 | [Power of Attorney (included on the signature page hereof)](#power_001) |
| 107 | [Filing Fee Table](ea026111501ex-fee_brera.htm) |

---

**Item 10. Undertakings.**

(a) The undersigned registrant
 hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;(1) To file, during any period
 in which offers or sales are being made, a post-effective amendment to this registration statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) to include any prospectus
 required by Section 10(a)(3) of the Securities Act of 1933;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) to reflect in the prospectus
 any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof)
 which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement.
 Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
 offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering
 range may be reflected in the form of prospectus filed with the SEC pursuant to Rule 424(b) if, in the aggregate, the changes in
 volume and price represent no more than a 20% change in the maximum aggregate offering price set forth in the "Calculation
 of Registration Fee" table in the effective registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) to include any material
 information with respect to the plan of distribution not previously disclosed in the registration statement or any material change
 to such information in the registration statement,

*provided, however*, that subsections (i), (ii) and (iii) above do not apply if the information required to be included in a post-effective amendment by those subsections is contained in reports filed with or furnished to the SEC by the registrant pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 that are incorporated by reference in the registration statement, or is contained in a form of prospectus filed pursuant to Rule 424(b) that is part of the registration statement.

&nbsp;&nbsp;&nbsp;&nbsp;(2) That, for the purpose of
 determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration
 statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the
 initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(3) To remove from registration
 by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;(4) To file a post-effective
 amendment to the registration statement to include any financial statements required by Item 8.A of Form 20-F at the start of any
 delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3)
 of the Act (15 U.S.C. 77j(a)(3)) need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective
 amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other
 information in the prospectus is at least as current as the date of those financial statements. Notwithstanding the foregoing, with
 respect to registration statements on Form F-3, a post-effective amendment need not be filed to include financial statements and
 information required by Section 10(a)(3) of the Act or Item 8.A of Form 20-F if such financial statements and information are contained
 in periodic reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities
 Exchange Act of 1934 that are incorporated by reference in the Form F-3.

&nbsp;&nbsp;&nbsp;&nbsp;(5) That, for the purpose of
 determining liability under the Securities Act of 1933, as amended, to any purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Each prospectus filed by
 the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of this registration statement as of the date the filed prospectus
 was deemed part of and included in this registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Each prospectus required
 to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of this registration statement in reliance on Rule 430B relating
 to an offer made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a)
 of the Securities Act of 1933, as amended, shall be deemed to be part of and included in this registration statement as of the earlier
 of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in
 the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at
 that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities
 in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed
 to be the initial bona fide offering thereof. *Provided, however,* that no statement made in a registration statement or prospectus
 that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration
 statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior
 to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part
 of the registration statement or made in any such document immediately prior to such effective date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(6) That, for the purpose of
 determining liability of the registrant under the Securities Act of 1933, as amended, to any purchaser in the initial distribution
 of the securities:

The undersigned registrant undertakes that in an offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) Any preliminary prospectus
 or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) Any free writing prospectus
 relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) The portion of any other
 free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities
 provided by or on behalf of the undersigned registrant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) Any other communication
 that is an offer in the offering made by the undersigned registrant to the purchaser.

&nbsp;&nbsp;&nbsp;&nbsp;(b) That, for purposes of determining
 any liability under the Securities Act of 1933, as amended, each filing of the registrant's annual report pursuant to Section
 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (and, where applicable, each filing of an employee benefit plan's
 annual report pursuant to Section 15(d) of the Securities Exchange Act of 1934, as amended), that is incorporated by reference in
 the registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the
 offering of such securities at that time shall be deemed to be the initial *bona fide* offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar as indemnification
 for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant
 pursuant to the foregoing provisions, or otherwise, the registrant has been advised that in the opinion of the Securities and Exchange
 Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that
 a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a
 director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted
 by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in
 the opinion of its counsel has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question
 whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication
 of such issue.

&nbsp;&nbsp;&nbsp;&nbsp;(d) The undersigned registrant
 hereby undertakes that:

&nbsp;&nbsp;&nbsp;&nbsp;(1) For purposes of determining
 any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration
 statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b) (1) or
 (4) or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

&nbsp;&nbsp;&nbsp;&nbsp;(2) For the purpose of determining
 any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed
 to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall
 be deemed to be the initial bona fide offering thereof.

**SIGNATURES**

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-3 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Miami, FL on November 19, 2025.

---

| | |
|:---|:---|
| **BRERA HOLDINGS PLC** | **BRERA HOLDINGS PLC** |
| By: | /s/ *Marco Santori* |
|  | Marco Santori |
|  | Chief Executive Officer |

---

**POWER OF ATTORNEY**

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below hereby constitutes and appoints Marco Santori and Daniel Joseph McClory, and each of them, his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments, including post-effective amendments, to this registration statement, and any registration statement relating to the offering covered by this registration statement and filed pursuant to Rule 462(b) under the Securities Act of 1933, and to file the same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully for all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys in fact and agents or their substitute or substitutes may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Signature** | **Title** | **Date** |
| */s/* Marco Santori | Chief Executive Officer (Principal Executive Officer) and Director | November 19, 2025 |
| Marco Santori |  |  |
| */s/* Dr. Fabio Scacciavillani | Chief Financial Officer (Principal Financial and Accounting Officer) | November 19, 2025 |
| Dr. Fabio Scacciavillani |  |  |
| */s/* Daniel Joseph McClory | Director | November 19, 2025 |
| Daniel Joseph McClory |  |  |
| */s/* Alberto Libanori | Director | November 19, 2025 |
| Alberto Libanori |  |  |
| */s/ Dr. Arthur Laffer* | Director | November 19, 2025 |
| Dr. Arthur Laffer |  |  |
| */s/ Viktor Fischer* | Director | November 19, 2025 |
| Viktor Fischer |  |  |
| */s/ Keren Maimon* | Director | November 19, 2025 |
| Keren Maimon |  |  |
| */s/ Ron Sade* | Director | November 19, 2025 |
| Ron Sade |  |  |
| */s/ Alyazi Almheiri* | Director | November 19, 2025 |
| Alyazi Almheiri |  |  |
| */s/ Tarek Alnuaimi* | Director | November 19, 2025 |
| Tarek Alnuaimi |  |  |

---

**SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES**

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant's duly authorized representative has signed this registration statement on Form F-3 in New York, NY on November 19, 2025.

---

| | | |
|:---|:---|:---|
| **U.S. Authorized Representative** | **U.S. Authorized Representative** | **U.S. Authorized Representative** |
| By: | **Cogency Global Inc.** | **Cogency Global Inc.** |
|  | /s/ Colleen A. De Vries | /s/ Colleen A. De Vries |
|  | Name: | Colleen A. De Vries |
|  | Title: | Senior Vice-President on behalf of Cogency Global Inc. |

---

## Exhibit 4.36

**Exhibit 4.6**

**SECOND AMENDMENT TO** 

**BRERA HOLDINGS PUBLIC LIMITED COMPANY**

**2022 EQUITY INCENTIVE PLAN**

Second Amendment (this "<u>Amendment</u>") to the Brera Holdings Public Limited Company 2022 Equity Incentive Plan (the "<u>Plan</u>") is made as of September 16, 2025, in accordance with resolutions adopted by the shareholders of Brera Holdings PLC, a public limited company incorporated in the Republic of Ireland (the "<u>Company</u>").

This Amendment amends the Plan as follows:

1. Section 4.1 of the Plan is amended and restated in its entirety
to read as follows:

"Subject to adjustment in accordance with ***Section 11*** or otherwise by the Board, a total of 9,000,000 Class B Ordinary Shares shall be available for the grant of Awards under the Plan. Class B Ordinary Shares granted in connection with all Awards under the Plan shall be counted against this limit as one (1) Class B Ordinary Share for every one (1) Class B Ordinary Share granted in connection with such Award. During the terms of the Awards, the Company shall keep available for issue or transfer at all times the number of Class B Ordinary Shares required to satisfy such Awards."

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date set forth above.

---

| | |
|:---|:---|
| BRERA HOLDINGS PLC | BRERA HOLDINGS PLC |
| By: |  |
|  | Name: Fabio Scacciavillan*i* |
|  | Title: Chief Executive Officer |

---

## Exhibit 5.1

**Exhibit 5.1**

19 November 2025

To:

Brera Holdings PLC

Connaught House

One Burlington Road

Dublin 4

D04 C5Y6

**Re: Brera Holdings Public Limited Company – CRO No. 721923 (the Company)**

Dear Sirs,

1. Introduction

We are instructed as Irish solicitors by the Board of Directors of the Company to provide certain Irish Law legal advice in connection with a registration statement (the "**Registration Statement**") on Form F-3, including prospectus dated November 19, 2025 (the "**Prospectus**") related to an automatic shelf registration statement filed with the U.S. Securities and Exchange Commission, relating to the shelf registration under the U.S. Securities Act of 1933, as amended of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A) up to 156,602,916 of our Class B Ordinary Shares, nominal value, $0.05 per share ("**Class B Ordinary Shares**") consisting of:

&nbsp;&nbsp;&nbsp;&nbsp;(i) 61,505,516 Class B Ordinary Shares issued to the investors in the PIPE Offering (as defined in the Registration
Statement)(the "**PIPE Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(ii) 10,372,130 Class B Ordinary Shares issued to the Strategic Advisors (as defined in the Registration Statement)
upon the partial exercise of the Strategic Advisor Pre-Funded Warrants (as defined in the Registration Statement) and the exercise in
full of the WPA Investor Warrants (as defined in the Registration Statement) (the "**Strategic Advisor Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(iii) 1,000,334 Class B Ordinary Shares issued to Daniel J. McClory or entities owned and controlled by Daniel
J. McClory (the "**McClory Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(iv) 5,858,695 Class B Ordinary Shares issued to Boustead & Company Limited upon the exercise in full of
three Class B Ordinary Share purchase warrants (the "**BCL Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(v) 93,887 Class B Ordinary Shares issued to Boustead Securities, LLC upon the exercise in full of several
warrants (the "**BSL Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(vi) 131,821 Class B Ordinary Shares issued to investors upon conversion of Class B Ordinary Shares (the "**Series B Conversion Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(vii) 785,971 shares issued to certain legacy shareholders of the Company (the "**Legacy Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(viii) up to 5,161,152 Class B Ordinary Shares issuable upon the exercise of the PIPE Pre-Funded Warrants (as
defined in the Registration Statement), which have an exercise price of $0.05 per share (the "**PIPE Pre-Funded Warrant Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(ix) up to 66,666,668 Class B Ordinary Shares issuable upon exercise of the PIPE Common Warrants (as defined
in the Registration Statement), which have an exercise price of $6.75 per share (the "**PIPE Warrant Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(x) up to 3,333,330 Class B Ordinary Shares issuable to the Strategic Advisors upon exercise of the Strategic
Advisor Pre-Funded Warrants (as defined in the Registration Statement) which have an exercise price of $0.05 per share (the "**Strategic Advisor Pre-Funded Warrant Shares** ");

&nbsp;&nbsp;&nbsp;&nbsp;(xi) up to 1,666,667 Class B Ordinary Shares issuable upon exercise of the Strategic Advisor Common Warrants
1 (as defined in the Registration Statement) which have an exercise price of $6.75 per share (the "**Strategic Advisor Shares** ");
and

&nbsp;&nbsp;&nbsp;&nbsp;(xii) 16,000 Class B Ordinary Shares issued to investors upon conversion of Series A Preferred Stock (the "**Series A Conversion Shares** "); and

&nbsp;&nbsp;&nbsp;&nbsp;(xiii) 10,745 Class B Ordinary Shares issuable upon warrants issued to certain legacy shareholders of the Company
(the "**Legacy Warrant Shares** "),

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B) warrants to purchase 76,827,817 Class B Ordinary Shares, consisting of:

&nbsp;&nbsp;&nbsp;&nbsp;(i) the PIPE Pre-Funded Warrants to purchase up to 5,161,152 Class B Ordinary Shares;

&nbsp;&nbsp;&nbsp;&nbsp;(ii) the PIPE Common Warrants to purchase up to 66,666,668 Class B Ordinary Shares,

&nbsp;&nbsp;&nbsp;&nbsp;(iii) Strategic Advisor Pre-Funded Warrants to purchase up to 3,333,330 Class B Ordinary Shares, and

&nbsp;&nbsp;&nbsp;&nbsp;(iv) the Strategic Advisor Common Warrants 1 to purchase up to 1,666,667 Class B Ordinary Shares.

We refer to the (i) PIPE Shares, (ii) the PIPE Pre-Funded Warrants, (iii) the PIPE Common Warrants, (iv) PIPE Pre-Funded Warrant Shares; (v) PIPE Warrant Shares, (vi) Strategic Advisor Shares, (vii) Strategic Advisor Pre- Funded Warrants, (viii) Strategic Advisor Common Warrants 1, (ix) Strategic Advisor Warrant Shares, (x) Legacy Shares, (xi) McClory Shares, (xii) BCL Shares, (xiii) BSL Shares, (xiv) Series A Conversion Shares, (xv) Series B Conversion Shares and (xvi) Legacy Warrant Shares, collectively as the "**Securities**" in this Legal Opinion.

(the **Transaction**)

This legal opinion is issued pursuant to the Legal Matters section of the Registration Statement (the "**Legal Opinion**").

In providing this Legal Opinion, we put you on express notice that we have reviewed only the documents listed in listed in Part 1 of Schedule 1 (each a "**Document**" and collectively, the "**Documents**") and undertaken only the searches and enquiries in relation to the Company described in Part 2 of Schedule 1 (the Searches). We have reviewed no other documents and have undertaken no other searches or enquiries.

2. Opinions

Based only on our review of the Documents and upon the assumptions set out in Schedule 2, and subject to all applicable bankruptcy, insolvency, liquidation, examinership, re-organisation, moratorium and other laws relating to the enforcement of creditors' rights generally and the qualifications set out in Schedule 3, we are of the following opinions as at today's date:

1) **Status and Incorporation:** The Company is a public limited company duly incorporated under the laws of Ireland, is in good standing and is validly existing under the laws of Ireland. The Company has its registered office at 5th Floor Rear, Connaught House, 1 Burlington Road, Dublin 4, Ireland registered in the Companies Registration Office under company number 721923. As of the date hereof, the Company's status is normal in the Companies Registration Office and there is no insolvency proceedings recorded as pending against the Company in the Companies Registration Office.

2) **Capacity**: Pursuant to its current Constitution (the "**Constitution**") the Company has the power and capacity to enter into, execute and perform its obligations as contemplated in the Documents.

3) **Duly Authorized**. The Registration Agreement has been duly authorized by all necessary corporate actions on the part of the Company and has been duly executed and delivered by the Company.

4) **Capital Stock**. The authorised capital stock of the Company consists of 5,000,000 Class A ordinary shares with a nominal value of $0.05 each, 10,025,000,000 Class B ordinary shares ordinary shares with a nominal value of $0.05 each, and 50,000,000 preferred shares with a nominal value of $0.005 each.

5) **No Conflict:** The execution and delivery of the Documents do not, and the performance by the Company of its obligations under the Documents will not, conflict with or result in a breach of any of the terms or provisions of the Constitution or any law, public rule or regulation applicable to the Company currently in force in Ireland.

6) No authorisations, consents, approvals, licences, validations or exemptions are required by law from any governmental authorities or agencies or other official bodies in Ireland in connection with:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the execution, creation or delivery of the Documents by and on behalf of the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) enforcement of the Documents against the Company; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the performance by the Company of its obligations under the Documents.

7) The Securities have been duly authorized for issuance, and when the Securities are issued and paid for in accordance with the Registration Statement, they will be validly issued, fully paid and non-assessable (which term, when used herein, means that the holders of the Securities are not liable, solely by virtue of holding such Securities, for additional assessments or calls on such Securities by the Company or its creditors) shares in the capital of the Company.

8) **Decision/Consents:** There are no further requirements to undertake any formal approval process by the Company in Ireland for entry into the Transaction.

3 Reliance

This Legal Opinion is solely for your benefit, solely for the purpose of the Registration Statement and may be relied on only by you. It may not be relied on for any other purpose or disclosed to, used by or circulated to any other person without our prior written consent in each instance which consent shall be at our absolute discretion.

We consent to the filing of this Legal Opinion as an exhibit to the Registration Statement and to the references to our firm under the captions "Legal Matters" and "Enforcement of Civil Liabilities" in the prospectus forming a part of the Registration Statement. In giving such consent, we do not hereby admit that we are experts within the meaning of Section 11 of the Securities Act or that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the Rules and Regulations of the Commission promulgated thereunder. We accept no liability to any recipient to which this Legal Opinion is disclosed in breach of this part 3.

We have taken instructions solely from the Company for the purpose of preparing the Legal Opinion.

This Legal Opinion is given by Clark Hill Solicitors LLP and no partner, member, or employee assumes any personal responsibility for it or shall owe any duty of care in respect of it.

4 Scope

The opinions in this Legal Opinion are strictly limited to the matters stated in part 2 and do not extend to any other matters.

We express no opinion on any taxation matters whether connected with the Transaction or otherwise.

We express no opinion on matters of fact. We have not been responsible for investigating or verifying the accuracy of the facts (including statements of foreign law), or the reasonableness of any statement of opinion or intention, contained in or relevant to any document referred to in this Legal Opinion, or that no material facts have been omitted from such documents.

This Legal Opinion and any non-contractual obligation arising out of it is given only in relation to Irish law as applied by the Irish courts as at the date of this Legal Opinion. By giving this Legal Opinion, we do not assume any obligation to notify you of future changes in law which may affect the opinions expressed in this Legal Opinion, or otherwise to update this letter in any respect.

We express no opinion on and have taken no account of the laws of any jurisdiction other than Ireland.

Yours faithfully

---

| |
|:---|
| **/s/ Clark Hill Solicitors LLP** |
| **Clark Hill Solicitors LLP** |

---

**SCHEDULE 1**

**PART 1**

Documents

The Registration Statement on Form F-3 filed with the Securities and Exchange Commission on November 19, 2025 (the "**Registration Statement**") for the purposes of the shelf registration process.

A written resolution of the board of directors of the Company dated November 17, 2025 (the "**Board Resolution**"),

Letter of Status from the Companies Registration Office dated November 17, 2025,

Companies Registration Office Printout dated November 19, 2025,

The certificate of incorporation of the Company (the "**Charter**"),

The Constitution of the Company,

The documents listed above are referred to as the **"Documents"** and individually a "**Document**".

**PART 2**

Searches

Searches made against Company by independent law searchers on our behalf on November 19, 2025:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) on the file of the Company maintained by the registrar of companies in the Companies Registration Office;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) in the Judgments Office of the High Court for unsatisfied judgments, orders, decrees and the like;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) in the Central Office of the High Court for any petitions for winding up filed in respect of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) in the Central Office of the High Court for any proceedings filed against the Company.

**SCHEDULE 2**

Assumptions

The opinions in part 2 of this Legal Opinion are made based on the following assumptions which we have made without independent verification:

1. That the Documents are complete, properly under seal as and where required by law and the Company constitution, authentic and up-to-date and that all copy documents are complete and accurate copies of the originals without any amendment or modification, that unsigned or unexecuted documents reviewed by us will be duly executed in the same form as that reviewed by us, all signatures and seals on the Documents are genuine, that any natural person who has signed a document has capacity to do so and is the person authorised in the Board Resolution, each party to the Documents has the capacity, power and authority to execute the Documents to which it is a party and to exercise its rights and perform its obligations under the Documents to which it is a party and in each case the Document has been authorize, executed and delivered by and to the said parties and that no Transaction is subject to an escrow, equivalent or like arrangement.

2. That the Securities will be issued and sold strictly in the manner and in the amounts provided for in the Documents.

3. The Documents constitute valid, legally binding and enforceable obligations of each of the parties under all applicable laws including where executed by electronic signature (other than Ireland)and to the extent that laws or regulations of any other jurisdiction may be relevant to parties and/or the Transaction such laws do not prohibit, and are not inconsistent with, the entry into and performance of any of the obligations created, rights given or transactions contemplated as part of the Documents .

4. That there is no provision of the laws of any jurisdiction (other than Ireland) that would have a bearing on any of the matters opined on in this Legal Opinion, including the execution of the Documents.

5. That each of the statements made in the Corporate Certificate and each of the documents attached to the Corporate Certificate is true, accurate and complete as of the date of this Legal Opinion.

6. That the resolutions of the board of directors of the Company in the Board Resolution are accurately and completely recorded have not been amended or rescinded and are in full force and effect.

7. That the provisions of the Documents do not breach and are not prohibited by or inconsistent with any other agreement or instrument binding on the Company, the directors of the Company acted in good faith, entered into the Documents for bona fide commercial reasons, on arm's length terms and that it is in the interests of and will commercially benefit the Company to enter into the Documents and where a director has a personal interest, this has been declared to the directors of the Company.

8. The Company is able to pay its debts (within the meaning of section 570 of the Companies Act 2014) at the time of entering into the Documents and will not become unable to pay its debts as a result of doing so. The Company has not passed any resolution for its winding-up or dissolution and no proceedings have been commenced or steps taken for its winding-up or for the appointment of an administrator, a liquidator, or receiver in relation to the Company or any of its assets or revenue. No analogous procedure or step has been taken in any jurisdiction in relation to the Company.

9. That any and all authorisation, consent or approval from any public, administrative or governmental body required by the Company in any jurisdiction in relation to the transactions contemplated by the Documents has been obtained and the Company has complied, and will continue to comply, with any conditions attaching to such authorisations, consents or approvals.

10. That all Securities to be issued and sold pursuant to the Transaction will have been issued and sold in compliance with all laws (other than Irish law), including applicable federal and state securities laws of the United States of America in the manner provided for in the Documents.

11. That the Company its servants, employees and agents were not induced by and did not themselves seek to induce any other party by means of, bad faith, fraud, misrepresentation, coercion, duress, undue influence or any similar circumstance the entering into of the Documents, and none of the parties is or will be seeking to achieve any benefit or purpose not apparent from the Documents which might render any of them illegal, void or unenforceable and there are no undisclosed agreements or arrangements in existence which in any way amend, or vary the terms of the Documents or the respective rights and interests of the parties to them that could affect the conclusions in this Legal Opinion.

12. That the representations and warranties by any of the parties to the Documents are and will, when made and/or repeated or when deemed made and/or repeated, in each case, be true, complete and accurate in all material respects.

13. That, the Company is not giving any financial assistance for the purposes of acquiring shares in the Company and for the purposes of section 239 of the Irish Companies Act 2014, the Company is not:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) making a loan or quasi-loan;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) entering into a credit transaction as creditor; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) entering into a guarantee or providing any security in connection with a loan, quasi-loan or credit transaction made by any other
person,

to or provided for or in connection with a person who is a director of the Company or of its holding company or to or for a person connected with such director.

14. That the information disclosed by the Searches is true, accurate, complete and up to date in all respects. There is no information which should have been disclosed by those Searches or otherwise that has not been disclosed for any reason and there has been no alteration in the status or condition of the Company since the date that those Searches were made and that there is no other fact, matter or document which would, or might, affect this Legal Opinion that was not revealed by the Documents or the Searches made.

15. That the shares in the capital of the Company will not be listed or admitted to trading on any stock exchange or public market other than under than the listing arrangements disclosed.

16. Any non-cash asset accepted as consideration by the Company for the issue of Securities has been appropriately valued and section 1029(4) of the Irish Companies Act 2014 does not apply to any such consideration, the value of the consideration accepted by the Company will equate to the nominal value plus the share premium when issued and no person has made a statement to which section 1030(4) of the Irish Companies Act 2014 applies that is, a statement which is false or misleading as to the value of such consideration.

17. The parties have complied (and will continue to comply) with all applicable anti-terrorism, anti-corruption, anti-money laundering and human rights laws and regulations and there is nothing in the Transaction that is inconsistent with all such laws and regulations.

18. That the Irish Takeover Panel Rules, as in force at the date of this Legal Opinion, have been duly complied with in all material respects by all relevant parties, and that no waiver, dispensation, derogation, or determination of the Irish Takeover Panel applies to the matters considered herein, other than as expressly disclosed to us.

19. That the Irish Takeover Panel will exercise its functions and exercise its functions in a lawful, rational and non-arbitrary manner, and will not vary, revoke, reinterpret or otherwise alter its published rules or practice in a way that would materially affect the conclusions expressed in this Legal Opinion.

 

*20.* The accuracy and completeness of all factual representations made in the Registration Statement and other documents reviewed by us.

**SCHEDULE 3**

Qualifications

The opinions in part 2 of this Legal Opinion are made subject to the following qualifications:

1. The searches and enquiries listed in Schedule 1 Part 2 of this Legal Opinion are not conclusively capable of revealing whether
or not (i) a winding up order has been made or a resolution passed for the winding up of the Company or (ii) a liquidator, administrator
or other manager has been appointed as notice of these matters may not be filed immediately and, when filed, may not be entered on the
public file immediately (and in addition, that search is not capable of revealing, prior to the making of the relevant order, whether
or not a winding up petition has been presented);

2. Under the laws of Ireland, a person who is not a party to any agreement is unable to enforce it.

&nbsp;&nbsp;&nbsp;&nbsp;3. In order to continue in good standing under the laws of Ireland, the Company is required, inter alia, to pay annual fees to and file
annual returns with the Companies Registration Office.

&nbsp;&nbsp;&nbsp;&nbsp;4. This Legal Opinion is subject to all insolvency, bankruptcy, liquidation, receivership, moratorium, reorganisation or similar laws
affecting the rights of creditors (including secured creditors) generally.

&nbsp;&nbsp;&nbsp;&nbsp;5. This Legal Opinion is based on information available as of the date of signature of this Legal Opinion, and we undertake no obligation
to update the Legal Opinion subsequently.

&nbsp;&nbsp;&nbsp;&nbsp;6. We have made no investigation as to whether or not sanctions may affect the Transaction at the date of
this Legal Opinion. Any obligation or right of a party to a Document who is directly or indirectly subject to sanction imposed or recognized
by Ireland is void.

&nbsp;&nbsp;&nbsp;&nbsp;7. We have made no investigation and express no opinion as to the adequacy of the consideration received
or to be received by the Company.

&nbsp;&nbsp;&nbsp;&nbsp;8. We have prepared this Legal Opinion on a diligent and careful basis. Our liability in respect of any error, omission, misstatement
or negligence in providing this Opinion shall be capped and restricted to the sum of $50,000,000 (fifty million US Dollars) in aggregate.

&nbsp;&nbsp;&nbsp;&nbsp;9. The Irish Takeover Panel has broad statutory powers of interpretation, discretion and intervention under the Irish Takeover Panel
Act 1997 (as amended) and the Irish Takeover Panel Rules. We express no opinion as to how the Irish Takeover Panel may exercise such powers
in practice, or as to the likelihood of the Irish Takeover Panel granting any waiver, dispensation or derogation from the application
of the Irish Takeover Rules.

## Exhibit 5.2

**Exhibit 5.2**

![](ex5-2_001.jpg)

November 19, 2025

Brera Holdings PLC

One Burlington Road

Dublin

D04 C5Y6

Ireland

To whom it may concern:

We have acted as United States securities law counsel to Brera Holdings PLC, a public limited company incorporated in Ireland (the "**Company**") in connection with filing with the U.S. Securities and Exchange Commission (**Commission**) of a registration statement on Form F-3 under the U.S. Securities Act of 1933, as amended (the "**Securities Act"**) (the "**Registration Statement**"), pursuant to which, among other things, certain selling securityholders named in the Registration Statement (each a "**Selling Securityholder**") may offer and sell the Company's (i) pre-funded warrants (the "Investor Pre-Funded Warrants") to purchase up to an aggregate of 5,161,152 Class B Ordinary Shares, nominal value, $0.05 (the "Class B Ordinary Shares"), (ii) Class B Ordinary Share purchase warrants (the "Investor Common Warrants") to purchase up to an aggregate of 66,666,668 Class B Ordinary Shares, (iii) pre-funded warrants (the "Strategic Advisor Pre-Funded Warrants") to purchase 3,333,330 Class B Ordinary Shares, and (iv) Class B Ordinary Share purchase warrants (the "Strategic Advisor Common Warrants" and together with the Investor Pre-Funded Warrants, the Investor Common Warrants, and the Strategic Advisor Pre-Funded Warrants , the "Securities") to purchase up to an aggregate of 1,666,667 Class B Ordinary Shares covered by the Registration Statement.

We have examined such documents and considered such legal matters as we have deemed necessary and relevant as the basis for the opinion set forth below. With respect to such examination, we have assumed the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as reproduced or certified copies, and the authenticity of the originals of those latter documents. As to questions of fact material to this opinion, we have, to the extent deemed appropriate, relied upon certain representations of certain officers of the Company. Because the Securities contain provisions stating that they are to be governed by the laws of the State of New York, we are rendering this opinion solely as to New York law and have assumed the due authorization, execution and delivery of each such agreement by the Company in accordance with the laws of Ireland. We are admitted to practice in the State of New York, and we express no opinion as to any matters governed by any law other than the law of the State of New York. In particular, we do not purport to pass on any matter governed by the laws of Ireland.

Based upon the foregoing, and subject to the additional qualifications set forth below, we are of the opinion that the Securities constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms.

1185 AVENUE OF THE AMERICAS \| 31ST FLOOR \| NEW YORK, NY \| 10036<br> T (212) 930-9700 \| F (212) 930-9725 \| WWW.SRFC.LAW

Page **2** of **2**

The opinion set forth above are subject to the following exceptions, limitations and qualifications: (i) the effect of bankruptcy, insolvency, reorganization, fraudulent conveyance, moratorium or other similar laws now or hereafter in effect relating to or affecting the rights and remedies of creditors; (ii) the effect of general principles of equity, including without limitation, concepts of materiality, reasonableness, good faith and fair dealing and the possible unavailability of specific performance or injunctive relief, regardless of whether enforcement is considered in a proceeding in equity or at law, and the discretion of the court before which any proceeding therefor may be brought; and (iii) the unenforceability under certain circumstances under law or court decisions of provisions providing for the indemnification of, or contribution to, a party with respect to liability where such indemnification or contribution is contrary to public policy. We express no opinion concerning the enforceability of any waiver of rights or defenses with respect to stay, extension or usury laws.

We hereby consent to the inclusion of this opinion as Exhibit 5.2 to the Registration Statement and to the references to our firm therein and in the Prospectus under the caption "Legal Matters." In giving our consent, we do not admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations thereunder.

---

| |
|:---|
| Very truly yours, |
| */s/ Sichenzia Ross Ference Carmel LLP* |
| Sichenzia Ross Ference Carmel LLP |

---

1185 AVENUE OF THE AMERICAS \| 31ST FLOOR \| NEW YORK, NY \| 10036<br> T (212) 930-9700 \| F (212) 930-9725 \| WWW.SRFC.LAW

## Exhibit 23.1

**Exhibit 23.1**

![](ex23-1_001.jpg)

Consent of Independent Registered Public Accounting Firm

To the Board of Directors of Brera Holdings PLC (f/k/a Brera Holdings Limited)

We hereby consent to the incorporation by reference in Brera Holdings PLC's (f/k/a Brera Holdings Limited) (the "Company") Registration Statements on Form F-3 of our report July 19, 2024 respect to our audit of the Company's consolidated financial statement as of and for the years ended December 31, 2023 and 2022, which appears in the Company's Annual Report on Form 20-F/A, filed on May 28, 2025.

We also consent to the reference to our Firm under the caption "Experts" in such Prospectus.

/s/ TAAD LLP

Diamond Bar, California

November 19, 2025

## Exhibit 23.2

**Exhibit 23.2**

![](ex23-2_001.jpg)

Consent of Independent Registered Public Accounting Firm

To the board of directors of Brera Holdings PLC

We hereby consent to the incorporation by reference in this Registration Statement on Form F-3 of Brera Holdings PLC (the "Company") of our report dated May 28, 2025, relating to the consolidated financial statements as of and for the year ended December 31, 2024, which appears in the Company's Annual Report on Form 20-F/A for the year ended December 31, 2024.

---

| |
|:---|
| /s/ Reliant CPA PC |
| **Reliant CPA PC** |

---

Newport Beach, CA

November 19, 2025

![](ex23-2_002.jpg)

## Exhibit 23.3

**Exhibit 23.3**

---

| |
|:---|
| &nbsp;&nbsp;Ria Gra nt Thornton S.p.A. |
| &nbsp;&nbsp;Via Maragliano, 6 |
| &nbsp;&nbsp;50144 F irenze |
| &nbsp;&nbsp;T +39 0 55 480112 |

---

**CONSENT OF INDEPENDENT AUDITORS**

We have issued our report dated September 29, 2025 with respect to the financial statements of Società Sportiva Juve Stabia s.r.l.,, included in Form 6-K of Brera Holding PLC. dated October 24, 2025 which is incorporated by reference in this Registration Statement. We consent to the incorporation by reference of the aforementioned report in this Registration Statement, and to the use of our name as it appears under the caption "Experts."

/s/ RIA GRANT THORNTON SPA

RIA GRANT THORNTON SPA

Florence, Italy

November 19th, 2025

![](ex23-3_002.jpg)

## Ex-Filing

?xml version='1.0' encoding='ASCII'? Filing Fee Exhibit

**Ex-Filing Fees**

**CALCULATION OF FILING FEE TABLES**

**F-3**

**Brera Holdings PLC**

**Table 1: Newly Registered and Carry Forward Securities**

---

| | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Line Item Type** | **Security Type** | **Security Class Title** | **Notes** | **Fee Calculation<br> Rule** | **Amount Registered** | **Proposed Maximum Offering<br> Price Per Unit** | **Maximum Aggregate Offering Price** | **Fee Rate** | **Amount of Registration Fee** |
| *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* | *Newly Registered Securities* |
| Fees to be Paid | Equity | Common Stock | (1) | Other | 156602916 | $6.52 | $1021051012.32 | 0.0001381 | $141007.14 |
| Fees to be Paid | Equity | PIPE Pre-Funded Warrants | (2) | Other |  |  |  | 0.0001381 | 0.00 |
| Fees to be Paid | Equity | PIPE Common Warrants | (3) | Other |  |  |  | 0.0001381 | 0.00 |
| Fees to be Paid | Equity | Strategic Advisor Pre-Funded Warrants | (4) | Other |  |  |  | 0.0001381 | 0.00 |
| Fees to be Paid | Equity | Strategic Advisor Warrants | (5) | Other |  | $— | $— | 0.0001381 | $0.00 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | $1021051012.32 |  | 141007.14 |
| Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: | Total Fees Previously Paid: |  |  | 0.00 |
| Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: | Total Fee Offsets: |  |  | 0.00 |
| Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: | Net Fee Due: |  |  | $141007.14 |

---

**__________________________________________ Offering Note(s)**

&nbsp;&nbsp;&nbsp;&nbsp;(1) Pursuant to Rule 416 of the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement shall also cover any additional shares of the Company's Class B Ordinary Shares, nominal value $0.05 ("Class B Ordinary Shares") that become issuable by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of outstanding Class B Ordinary Shares. The 156,602,916 Class B Ordinary Shares consist of (i) 61,505,516 Class B Ordinary Shares issued to the investors in the PIPE Offering (as defined herein)(the "PIPE Shares"); (ii) 10,372,130 Class B Ordinary Shares issued to the Strategic Advisors (as defined herein) upon the partial exercise of the Strategic Advisor Pre-Funded Warrants (as defined herein), the partial exercise of the Strategic Advisor Common Warrants 1 (as defined herein), the exercise in full of the Strategic Advisor Common Warrants 2 (as defined herein) and the exercise in full of the WPA Investor Warrants (as defined herein) (the "Strategic Advisor Shares"); (iii) 1,000,334 Class B Ordinary Shares issued to Daniel J. McClory or entities owned and controlled by Daniel J. McClory (the "McClory Shares"); (iv) 5,858,695 Class B Ordinary Shares issued to Boustead& Company Limited upon the exercise in full of three Class B Ordinary Share purchase warrants (the "BCL Shares"); (v) 93,887 Class B Ordinary Shares issued to Boustead Securities, LLC upon the exercise in full of several warrants (the "BSL Shares"); (vi) 131,821 Class B Ordinary Shares issued to investors upon conversion of Class B Preferred Stock (the "Series B Conversion Shares"); (vii) 785,971 shares issued to certain legacy shareholders of the Company (the "Legacy Shares"); (viii) up to 5,161,152 Class B Ordinary Shares issuable upon the exercise of the PIPE Pre-Funded Warrants (as defined herein), which have an exercise price of $0.05 per share (the "PIPE Pre-Funded Warrant Shares"); (ix) up to 66,666,668 Class B Ordinary Shares issuable upon exercise of the PIPE Common Warrants (as defined herein), which have an exercise price of $6.75 per share (the "PIPE Warrant Shares"); (x) up to 3,333,330 Class B Ordinary Shares issuable to the Strategic Advisors upon exercise of certain of the Strategic Advisor Pre-Funded Warrants (as defined herein) which have an exercise price of $0.05 per share (the "Strategic Advisor Pre-Funded Warrant Shares"); (xi) up to 1,666,667 Class B Ordinary Shares issuable upon exercise of the Strategic Advisor Common Warrants 1 (as defined herein) which have an exercise price of $6.75 per share (the "Strategic Advisor Warrant 1 Shares" and together with the Strategic Advisor Pre-Funded Warrant Shares, the Strategic Advisor Warrant Shares"); (xii) 16,000 Class B Ordinary Shares issuable upon conversion of Series A Preferred Stock (the "Series A Conversion Shares"); and (xiii)10,745 Class B Ordinary Shares issuable upon warrants issued to certain legacy shareholders of the Company, which have an exercise price of $13.50 per share (the "Legacy Warrant Shares") Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) and Rule 457(g) under the Securities Act. The offering price per share and aggregate offering price are based upon the average of the high and low prices per share of Class B Ordinary Shares of Brera Holdings PLC as reported on the Nasdaq Capital Market on November 14, 2025, which was $6.52. per share.

&nbsp;&nbsp;&nbsp;&nbsp;(2) Included in the price of the Class B Ordinary Shares. No separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;(3) Included in the price of the Class B Ordinary Shares. No separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;(4) Included in the price of the Class B Ordinary Shares. No separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended.

&nbsp;&nbsp;&nbsp;&nbsp;(5) Included in the price of the Class B Ordinary Shares. No separate registration fee required pursuant to Rule 457(g) under the Securities Act of 1933, as amended.